Search

Your search keyword '"N. Iida"' showing total 613 results
Start Over Author "N. Iida"
613 results on '"N. Iida"'

5. Role of right ventricular free wall longitudinal strain in prediction outcome in patients with cardiac sarcoidosis

Author

N Albakaa, K Sato, N Iida, M Yamamoto, T Machino, T Ishizu, and M Ieda

Subjects
Cardiology and Cardiovascular Medicine
Abstract

Introduction Right ventricular free wall longitudinal strain (RVFWLS) is a sensitive tool for right ventricular (RV) function assessment. Furthermore, it shows incremental prognostic role in various cardiac diseases. RV involvement is frequently observed along with left ventricular (LV) involvement in cardiac sarcoidosis (CS) patients, while its impact on outcome is unclear. Purpose The aim of this study is to investigate the association between RV dysfunction detected by RVFWLS and cardiovascular event in patients with CS. Methods We retrospectively evaluated 51 patients with CS who were treated with prednisone from 2012 through 2020. Diagnosis of CS was made according to the Japanese Circulation Society diagnostic criteria. We evaluated RVFWLS at baseline using vender-independent software. We considered major adverse cardiovascular event (MACE: ventricular arrhythmia, heart failure hospitalization) to be the primary outcome. Results Mean age of the study population was 63±11 years, and 61% were female. At baseline, 25 patients (49%) had reduced left ventricular (LV) ejection fraction (EF) ( Conclusions In patients with CS, RVFWLS is an independent predictor for MACE. RVFWLS may be valuable in improving risk stratification in CS. Funding Acknowledgement Type of funding sources: None. Kaplan-Meier survival curves

Published
2021
Full Text
View/download PDF

6. Measurements of Beam Backgrounds in SuperKEKB Phase 2

Author

Z. Liptak, A. Paladino, L. Santelj, J. Schueler, S. Stefkova, H. Tanigawa, N. Tsuzuki, A. Aloisio, P. Ahlburg, P. Bambade, G. Bassi, M. Barrett, J. Baudot, T.E. Browder, G. Casarosa, G. Cautero, D. Cinabro, G. Claus, D. Cuesta, F. Di Capua, S. Di Carlo, J. Flanagan, A. Frey, B.G. Fulsom, Y. Funakoshi, M. Gabriel, R. Giordano, D. Giuressi, M. Goffe, K. Hara, O. Hartbrich, M.T. Hedges, D. Heuchel, N. Iida, T. Ishibashi, K. Jaaskelainen, D. Jehanno, S. de Jong, T. Kraetzschmar, C. La Licata, L. Lanceri, P. Leitl, P.M. Lewis, C. Marinas, C. Miller, H. Moser, K.R. Nakamura, H. Nakayama, C. Niebuhr, Y. Onuki, C. Pang, B. Paschen, I. Ripp-Baudot, G. Rizzo, J.M. Roney, H. Schreeck, B. Schwenker, F. Simon, M. Specht, B. Spruck, Y. Soloviev, M. Szelezniak, S. Tanaka, S. Terui, G. Tortone, T. Tsuboyama, Y. Uematsu, S.E. Vahsen, L. Vitale, H. Windel, Liptak, Z., Paladino, A., Santelj, L., Schueler, J., Stefkova, S., Tanigawa, H., Tsuzuki, N., Aloisio, A., Ahlburg, P., Bambade, P., Bassi, G., Barrett, M., Baudot, J., Browder, T. E., Casarosa, G., Cautero, G., Cinabro, D., Claus, G., Cuesta, D., Di Capua, F., Di Carlo, S., Flanagan, J., Frey, A., Fulsom, B. G., Funakoshi, Y., Gabriel, M., Giordano, R., Giuressi, D., Goffe, M., Hara, K., Hartbrich, O., Hedges, M. T., Heuchel, D., Iida, N., Ishibashi, T., Jaaskelainen, K., Jehanno, D., de Jong, S., Kraetzschmar, T., La Licata, C., Lanceri, L., Leitl, P., Lewis, P. M., Marinas, C., Miller, C., Moser, H., Nakamura, K. R., Nakayama, H., Niebuhr, C., Onuki, Y., Pang, C., Paschen, B., Ripp-Baudot, I., Rizzo, G., Roney, J. M., Schreeck, H., Schwenker, B., Simon, F., Specht, M., Spruck, B., Soloviev, Y., Szelezniak, M., Tanaka, S., Terui, S., Tortone, G., Tsuboyama, T., Uematsu, Y., Vahsen, S. E., Vitale, L., and Windel, H.

Subjects
Nuclear and High Energy Physics, Physics - Instrumentation and Detectors, FOS: Physical sciences, SuperKEKB, Instrumentation and Detectors (physics.ins-det), Accelerator background, High Energy Physics - Experiment, Beam background, High Energy Physics - Experiment (hep-ex), Belle II, Physics::Accelerator Physics, High Energy Physics::Experiment, Instrumentation
Abstract

The high design luminosity of the SuperKEKB electron-positron collider will result in challenging levels of beam-induced backgro\ unds in the interaction region. Understanding and mitigating these backgrounds is critical to the success of the Belle~II experi\ ment. We report on the first background measurements performed after roll-in of the Belle II detector, a period known as SuperKE\ KB Phase 2, utilizing both the BEAST II system of dedicated background detectors and the Belle II detector itself. We also repor\ t on first revisions to the background simulation made in response to our findings. Backgrounds measured include contributions f\ rom synchrotron radiation, beam-gas, Touschek, and injection backgrounds. At the end of Phase 2, single-beam backgrounds origina\ ting from the 4 GeV positron Low Energy Ring (LER) agree reasonably well with simulation, while backgrounds from the 7 GeV elect\ ron High Energy Ring (HER) are approximately one order of magnitude higher than simulation. We extrapolate these backgrounds for\ ward and conclude it is safe to install the Belle II vertex detector., Comment: 22 Pages, 33 figures

Published
2021
Full Text
View/download PDF

7. Association between male nocturia and smoking exposure: Does smoking cessation improve nocturia?

Author

H. Suzuki, Y. Nakanishi, K. Tobisu, N. Iida, H. Fuse, Masaaki Ito, M. Kataoka, F. Koga, and K. Takemura

Subjects
medicine.medical_specialty, business.industry, Urology, medicine.medical_treatment, lcsh:Diseases of the genitourinary system. Urology, lcsh:RC870-923, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, lcsh:RC254-282, Internal medicine, Tobacco exposure, medicine, Smoking cessation, Nocturia, medicine.symptom, business
Published
2020

8. Prediction models of muscle-invasive and locally advanced upper tract urothelial cancer incorporating diffusion-weighted MRI

Author

N. Iida, H. Fuse, K. Tobisu, Fumitaka Koga, M. Kataoka, K. Takemura, H. Suzuki, Y. Nakanishi, and Masaaki Ito

Subjects
medicine.medical_specialty, business.industry, Urology, Locally advanced, Muscle invasive, lcsh:Diseases of the genitourinary system. Urology, lcsh:RC870-923, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, lcsh:RC254-282, Upper tract, medicine, Urothelial cancer, Radiology, business, Diffusion MRI
Published
2020

9. Impact of severe chronic kidney disease on severe nocturia in men

Author

H. Suzuki, F. Koga, H. Fuse, M. Kataoka, K. Tobisu, N. Iida, Masaaki Ito, K. Takemura, and Y. Nakanishi

Subjects
medicine.medical_specialty, business.industry, Urology, medicine.disease, lcsh:Diseases of the genitourinary system. Urology, lcsh:RC870-923, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, lcsh:RC254-282, medicine, Nocturia, medicine.symptom, business, Kidney disease
Published
2020

10. Prognostic impact of controlling nutritional status (CONUT) score in metastatic renal cell carcinoma patients

Author

Y. Nakanishi, M. Kataoka, H. Fukushima, N. Iida, K. Takemura, F. Koga, K. Tobisu, H. Fuse, H. Suzuki, K. Sekiya, and Masaaki Ito

Subjects
Oncology, medicine.medical_specialty, business.industry, Urology, Nutritional status, lcsh:Diseases of the genitourinary system. Urology, lcsh:RC870-923, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, lcsh:RC254-282, Renal cell carcinoma, Internal medicine, medicine, business
Published
2020
Full Text
View/download PDF

11. Clinical presentation, aetiology and outcomes of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study

Author

Habib G., Erba P. A., Iung B., Donal E., Cosyns B., Laroche C., Popescu B. A., Prendergast B., Tornos P., Sadeghpour A., Oliver L., Vaskelyte J. -J., Sow R., Axler O., Maggioni A. P., Lancellotti P, C P Gale, B Beleslin, A Budaj, O Chioncel, N Dagres, N Danchin, J Emberson, D Erlinge, M Glikson, A Gray, M Kayikcioglu, A P Maggioni, V K Nagy, A Nedoshivin, A-S Petronio, J Roos-Hesselink, L Wallentin, U Zeymer, G Habib, P Lancellotti, B Cosyns, E Donal, P Erba, B Iung, B A Popescu, B Prendergast, P Tornos, M Andarala, C Berle, A Brunel-Lebecq, E Fiorucci, C Laroche, V Missiamenou, C Taylor, N N Ali Tatar-Chentir, M Al-Mallah, M Astrom Aneq, G Athanassopoulos, L P Badano, S Benyoussef, E Calderon Aranda, N M Cardim, K-L Chan, I Cruz, T Edvardsen, G Goliasch, A Hagendorff, K Hristova, O Kamp, D-H Kang, W Kong, S Matskeplishvili, M Meshaal, M Mirocevic, A N Neskovic, M Pazdernik, E Plonska-Gosciniak, M Raissouni, R Ronderos, L E Sade, A Sadeghpour, A Sambola, S Sengupta, J Separovic-Hanzevacki, M Takeuchi, E Tucay, A C Tude Rodrigues, A Varga, J Vaskelyte, K Yamagata, K Yiangou, H Zaky, I Granada, M Mahia, S Ressi, F Nacinovich, A Iribarren, P Fernandez Oses, G Avegliano, E Filipini, R Obregon, M Bangher, J Dho, L Cartasegna, M L Plastino, V Novas, C Shigel, G Reyes, M De Santos, N Gastaldello, M Granillo Fernandez, M Potito, G Streitenberger, P Velazco, J H Casabé, C Cortes, E Guevara, F Salmo, M Seijo, F Weidinger, M Heger, R Brooks, C Stöllberger, C-Y Ho, L Perschy, L Puskas, C Binder, R Rosenhek, M Schneider, M-P Winter, E Hoffer, M Melissopoulou, E Lecoq, D Legrand, S Jacquet, M Massoz, L Pierard, S Marchetta, R Dulgheru, C D Emal, C Oury, S Droogmans, D Kerkhove, D Plein, L Soens, C Weytjens, A Motoc, B Roosens, I Lemoine, I Rodrigus, B Paelinck, B Amsel, P Unger, D Konopnicki, C Beauloye, A Pasquet, J L Vanoverschelde, S Pierard, D Vancraeynest, F Sinnaeve, J L Andrade, K Staszko, R Dos Santos Monteiro, M H Miglioranza, D L Shuha, M Alcantara, V Cravo, L Fazzio, A Felix, M Iso, C Musa, A P Siciliano, F Villaca Filho, A Rodrigues, F Vilela, J Braga, R Silva, D Rodrigues, L Silva, S Morhy, C Fischer, M Vieira, T Afonso, J Abreu, S N Falcao, V A Moises, A Gouvea, F J Mancuso, A C Souza, C Y Silva, G João, C S Abboud, R Bellio de Mattos Barretto, A Ramos, R Arnoni, J E Assef, D J Della Togna, D Le Bihan, L Miglioli, A P Romero Oliveira, R Tadeu Magro Kroll, D Cortez, C L Gelape, M D C Peirira Nunes, T C De Abreu Ferrari, K Hay, V Le, M Page, F Poulin, C Sauve, K Serri, C Mercure, J Beaudoin, P Pibarot, I A Sebag, L G Rudski, G Ricafort, B Barsic, V Krajinovic, M Vargovic, D Lovric, V Reskovic-Luksic, J Vincelj, S Jaksic Jurinjak, V Yiannikourides, M Ioannides, C Pofaides, V Masoura, J Pudich, A Linhart, M Siranec, J Marek, K Blechova, M Kamenik, R Pelouch, Z Coufal, M Mikulica, M Griva, E Jancova, M Mikulcova, M Taborsky, J Precek, M Jecmenova, J Latal, J Widimsky, T Butta, S Machacek, R Vancata, J Spinar, M Holicka, F Pow Chon Long, N Anzules, A Bajana Carpio, G Largacha, E Penaherrera, D Moreira, E Mahfouz, E Elsafty, A Soliman, Y Zayed, J Aboulenein, M Abdel-Hay, A Almaghraby, M Abdelnaby, M Ahmed, B Hammad, Y Saleh, H Zahran, O Elgebaly, A Saad, M Ali, A Zeid, R El Sharkawy, A Al Kholy, R Doss, D Osama, H Rizk, A Elmogy, M Mishriky, P Assayag, S El Hatimi, S Hubert, J-P Casalta, F Gouriet, F Arregle, S Cammilleri, L Tessonnier, A Riberi, E Botelho-Nevers, A Gagneux-Brunon, R Pierrard, C Tulane, S Campisi, J-F Fuzellier, M Detoc, T Mehalla, D Boutoille, A S Lecompte, M Lefebvre, S Pattier, O Al Habash, N Asseray-Madani, C Biron, J Brochard, J Caillon, C Cueff, T Le Tourneau, R Lecomte, M M Magali Michel, J Orain, S Delarue, M Le Bras, J-F Faucher, V Aboyans, A Beeharry, H Durox, M Lacoste, J Magne, D Mohty, A David, V Pradel, V Sierra, A Neykova, B Bettayeb, S Elkentaoui, B Tzvetkov, G Landry, C Strady, K Ainine, S Baumard, C Brasselet, C Tassigny, V Valente-Pires, M Lefranc, B Hoen, B Lefevre, E Curlier, C Callier, N Fourcade, Y Jobic, S Ansard, R Le Berre, F Le Ven, M-C Pouliquen, G Prat, P Le Roux, F Bouchart, A Savoure, C Alarcon, C Chapuzet, I Gueit, C Tribouilloy, Y Bohbot, F Peugnet, M Gun, X Duval, X Lescure, E Ilic-Habensus, N Sadoul, C Selton-Suty, F Alla, F Goehringer, O Huttin, E Chevalier, R Garcia, V Le Marcis, P Tattevin, E Flecher, M Revest, C Chirouze, K Bouiller, L Hustache-Mathieu, T Klopfenstein, J Moreau, D Fournier, A-S Brunel, P Lim, L Oliver, J Ternacle, A Moussafeur, P Chavanet, L Piroth, A Salmon-Rousseau, M Buisson, S Mahy, C Martins, S Gohier, O Axler, F Baumann, S Lebras, C Piper, D Guckel, J Börgermann, D Horstkotte, E Winkelmann, B Brockmeier, D Grey, G Nickenig, R Schueler, C Öztürk, E Stöhr, C Hamm, T Walther, R Brandt, A-C Frühauf, C T Hartung, C Hellner, C Wild, M Becker, S Hamada, W Kaestner, K Stangl, F Knebel, G Baldenhofer, A Brecht, H Dreger, C Isner, F Pfafflin, M Stegemann, R Zahn, B Fraiture, C Kilkowski, A-K Karcher, S Klinger, H Tolksdorf, D Tousoulis, C Aggeli, S Sideris, E Venieri, G Sarri, D Tsiapras, I Armenis, A Koutsiari, G Floros, C Grassos, S Dragasis, L Rallidis, C Varlamos, L Michalis, K Naka, A Bechlioulis, A Kotsia, L Lakkas, K Pappas, C Papadopoulos, S Kiokas, A Lioni, S Misailidou, J Barbetseas, M Bonou, C Kapelios, I Tomprou, K Zerva, A Manolis, E Hamodraka, D Athanasiou, G Haralambidis, H Samaras, L Poulimenos, A Nagy, A Bartykowszki, E Gara, K Mungulmare, R Kasliwal, M Bansal, S Ranjan, A Bhan, M Kyavar, M Maleki, F Noohi Bezanjani, A Alizadehasl, S Boudagh, A Ghavidel, P Moradnejad, H R Pasha, B Ghadrdoost, D Gilon, J Strahilevitz, M Wanounou, S Israel, C d'Agostino, P Colonna, L De Michele, F Fumarola, M Stante, N Marchionni, V Scheggi, B Alterini, S Del Pace, P Stefano, C Sparano, N Ruozi, R Tenaglia, D Muraru, U Limbruno, A Cresti, P Baratta, M Solari, C Giannattasio, A Moreo, B De Chiara, B Lopez Montero, F Musca, C A Orcese, F Panzeri, F Spano, C F Russo, O Alfieri, M De Bonis, S Chiappetta, B Del Forno, M Ripa, P Scarpellini, C Tassan Din, B Castiglioni, R Pasciuta, S Carletti, D Ferrara, M Guffanti, G Iaci, E Lapenna, T Nisi, C Oltolini, E Busnardo, U Pajoro, E Agricola, R Meneghin, D Schiavi, F Piscione, R Citro, R M Benvenga, L Greco, L Soriente, I Radano, C Prota, M Bellino, D Di Vece, F Santini, A Salsano, G M Olivieri, F Turrini, R Messora, S Tondi, A Olaru, V Agnoletto, L Grassi, C Leonardi, S Sansoni, S Del Ponte, G M Actis Dato, A De Martino, N Ohte, S Kikuchi, K Wakami, K Aonuma, Y Seo, T Ishizu, T Machino-Ohtsuka, M Yamamoto, N Iida, H Nakajima, Y Nakagawa, C Izumi, M Amano, M Miyake, K Takahashi, I Shiojima, Y Miyasaka, H Maeba, Y Suwa, N Taniguchi, S Tsujimoto, T Kitai, M Ota, S Yuda, S Sasaki, N Hagiwara, K Yamazaki, K Ashihara, K Arai, C Saitou, S Saitou, G Suzuki, Y Shibata, N Watanabe, S Nishino, K Ashikaga, N Kuriyama, K Mahara, T Okubo, H Fujimaki, H Shitan, H Yamamoto, K Abe, M Terada, S Takanashi, M Sata, H Yamada, K Kusunose, Y Saijo, H Seno, O Yuichiro, T Onishi, F Sera, S Nakatani, H Mizuno, K Sengoku, S W Park, K Eun Kyoung, L Ga Yeon, J-W Hwang, C Jin-Oh, S-J Park, L Sang-Chol, C Sung-A, S Y Jang, R Heo, S Lee, J-M Song, E Jung, J Plisiene, A Dambrauskaite, G Gruodyte, R Jonkaitiene, V Mizariene, J Atkocaityte, R Zvirblyte, R Sow, A Codreanu, T Staub, C Michaux, E C L De la Vega, L Jacobs-Orazi, C Mallia Azzopardi, R G Xuereb, T Piscopo, J Farrugia, M Fenech, E Pllaha, C Vella, D Borg, R Casha, L Grib, E Raevschi, A Grejdieru, D Kravcenco, E Prisacari, E Samohvalov, S Samohvalov, N Sceglova, E Panfile, L Cardaniuc, V Corcea, A Feodorovici, V Gaina, L Girbu, P Jimbei, G Balan, I Cardaniuc, I Benesco, V Marian, N Sumarga, B Bozovic, N Bulatovic, P Lakovic, L Music, R Budde, A Wahadat, T Gamela, T Meijers, J P Van Melle, V M Deursen, H J Crijns, S C Bekkers, E C Cheriex, M Gilbers, B L Kietselaer, C Knackstedt, R Lorusso, S Schalla, S A Streukens, S Chamuleau, M-J Cramer, A Teske, T Van der Spoel, A Wind, J Lokhorst, O Liesbek, H Van Heusden, W Tanis, I Van der Bilt, J Vriend, H De Lange-van Bruggen, E Karijodikoro, R Riezebos, E van Dongen, J Schoep, V Stolk, J T Offstad, J O Beitnes, T Helle-Valle, H Skulstad, R Skardal, N Qamar, S Furnaz, B Ahmed, M H Butt, M F Khanzada, T Saghir, A Wahid, T Hryniewiecki, P Szymanski, K Marzec, M Misztal-Ogonowska, W Kosmala, M Przewlocka-Kosmala, A Rojek, K Woznicka, J Zachwyc, A Lisowska, M Kaminska, J D Kasprzak, E Kowalczyk, D F Strzecka, P Wejner-Mik, M Trabulo, P Freitas, S Ranchordas, G Rodrigues, P Pinto, C Queiros, J Azevedo, L Marques, D Seabra, L Branco, M Cruz, A Galrinho, R Moreira, P Rio, A T Timoteo, M Selas, V Carmelo, B Duque Neves, H Pereira, A Guerra, A Marques, I Pintassilgo, M C Tomescu, N-M Trofenciuc, M Andor, A Bordejevic, H S Branea, F Caruntu, L A Velcean, A Mavrea, M F Onel, T Parvanescu, D Pop, A L Pop-Moldovan, M I Puticiu, L Cirin, I M Citu, C A Cotoraci, D Darabantiu, R Farcas, I Marincu, A Ionac, D Cozma, C Mornos, F Goanta, I Popescu, R Beyer, R Mada, R Rancea, R Tomoaia, H Rosianu, C Stanescu, Z Kobalava, J Karaulova, E Kotova, A Milto, A Pisaryuk, N Povalyaev, M Sorokina, J Alrahimi, A Elshiekh, A Jamiel, A Ahmed, N Attia, B Putnikovic, A Dimic, B Ivanovic, S Matic, D Trifunovic, J Petrovic, D Kosevic, I Stojanovic, I Petrovic, P Dabic, P Milojevic, I Srdanovic, S Susak, L Velicki, A Vulin, M Kovacevic, A Redzek, M Stefanovic, T C Yeo, W Kf Kong, K K Poh, I Vilacosta, C Ferrera, C Olmos, M Abd El-Nasser, F Calvo Iglesias, E Blanco-Gonzalez, M Bravo Amaro, E Lopez-Rodriguez, J Lugo Adan, A N Germinas, P Pazos-Lopez, M Pereira Loureiro, M T Perez, S Raposeiras-Roubin, S Rasheed Yas, M-M Suarez-Varela, F Vasallo Vidal, D Garcia-Dorado, N Fernandez-Hidalgo, T Gonzalez-Alujas, J Lozano, O Maisterra, N Pizzi, R Rios, A Bayes-Genis, L Pedro Botet, N Vallejo, C Llibre, L Mateu, R Nunez, D Quesada, E Berastegui, D Bosch Portell, J Aboal Vinas, X Albert Bertran, R Brugada Tarradellas, P Loma-Osorio Ricon, C Tiron de Llano, M A Arnau, A Bel, M Blanes, A Osa, M Anguita, F Carrasco, J C Castillo, J L Zamorano, J L Moya Mur, M Alvaro, C Fernandez-Golfin, J M Monteagudo, E Navas Elorza, M C Farinas Alvarez, J Aguero Balbin, J Zarauza, J F Gutierrez-Diez, C Arminanzas, F Arnaiz de Las Revillas, A Arnaiz Garcia, M Cobo Belaustegui, M Fernandez Sampedro, M Gutierrez Cuadra, L Garcia Cuello, C Gonzalez Rico, R Rodriguez-Alvarez, J Goikoetxea, M Montejo, J M Miro, M Almela, J Ambrosioni, A Moreno, E Quintana, E Sandoval, A Tellez, J M Tolosana, B Vidal, C Falces, D Fuster, C Garcia-de-la-Maria, M Hernandez-Meneses, J Llopis, F Marco, I Ruiz-Zamora, A Bardaji Ruiz, E Sanz Girgas, G Garcia-Pardo, M Guillen Marzo, A Rodriguez Oviedo, A Villares Jimenez, L Abid, R Hammami, S Kammoun, M S Mourali, F Mghaieth Zghal, M Ben Hlima, S Boudiche, S Ouali, L Zakhama, S Antit, I Slama, O Gulel, M Sahin, E Karacaglar, S Kucukoglu, O Cetinarslan, U Y Sinan, U Canpolat, B Mutlu, H Atas, R Dervishova, C Ileri, J Alhashmi, J Tahir, P Zarger, F Baslib, S Woldman, L Menezes, C Primus, R Uppal, I Bvekerwa, B Chandrasekaran, A Kopanska, J Chambers, J Hancock, J Klein, R Rajani, M P Ursi, S Cannata, R Dworakowski, A Fife, J Breeze, M Browne-Morgan, M Gunning, S Streather, F M Asch, M Zemedkun, B Alyavi, J Uzokov, G., Habib, P. A., Erba, B., Iung, E., Donal, B., Cosyn, C., Laroche, B. A., Popescu, B., Prendergast, P., Torno, A., Sadeghpour, L., Oliver, J. -J., Vaskelyte, R., Sow, O., Axler, A. P., Maggioni, P, Lancellotti, P Gale, C, Beleslin, B, Budaj, A, Chioncel, O, Dagres, N, Danchin, N, Emberson, J, Erlinge, D, Glikson, M, Gray, A, Kayikcioglu, M, P Maggioni, A, K Nagy, V, Nedoshivin, A, Petronio, A-S, Roos-Hesselink, J, Wallentin, L, Zeymer, U, Habib, G, Lancellotti, P, Cosyns, B, Donal, E, Erba, P, Iung, B, A Popescu, B, Prendergast, B, Tornos, P, Andarala, M, Berle, C, Brunel-Lebecq, A, Fiorucci, E, Laroche, C, Missiamenou, V, Taylor, C, N Ali Tatar-Chentir, N, Al-Mallah, M, Astrom Aneq, M, Athanassopoulos, G, P Badano, L, Benyoussef, S, Calderon Aranda, E, M Cardim, N, Chan, K-L, Cruz, I, Edvardsen, T, Goliasch, G, Hagendorff, A, Hristova, K, Kamp, O, Kang, D-H, Kong, W, Matskeplishvili, S, Meshaal, M, Mirocevic, M, N Neskovic, A, Pazdernik, M, Plonska-Gosciniak, E, Raissouni, M, Ronderos, R, E Sade, L, Sadeghpour, A, Sambola, A, Sengupta, S, Separovic-Hanzevacki, J, Takeuchi, M, Tucay, E, C Tude Rodrigues, A, Varga, A, Vaskelyte, J, Yamagata, K, Yiangou, K, Zaky, H, Granada, I, Mahia, M, Ressi, S, Nacinovich, F, Iribarren, A, Fernandez Oses, P, Avegliano, G, Filipini, E, Obregon, R, Bangher, M, Dho, J, Cartasegna, L, L Plastino, M, Novas, V, Shigel, C, Reyes, G, De Santos, M, Gastaldello, N, Granillo Fernandez, M, Potito, M, Streitenberger, G, Velazco, P, H Casabé, J, Cortes, C, Guevara, E, Salmo, F, Seijo, M, Weidinger, F, Heger, M, Brooks, R, Stöllberger, C, Ho, C-Y, Perschy, L, Puskas, L, Binder, C, Rosenhek, R, Schneider, M, Winter, M-P, Hoffer, E, Melissopoulou, M, Lecoq, E, Legrand, D, Jacquet, S, Massoz, M, Pierard, L, Marchetta, S, Dulgheru, R, D Emal, C, Oury, C, Droogmans, S, Kerkhove, D, Plein, D, Soens, L, Weytjens, C, Motoc, A, Roosens, B, Lemoine, I, Rodrigus, I, Paelinck, B, Amsel, B, Unger, P, Konopnicki, D, Beauloye, C, Pasquet, A, L Vanoverschelde, J, Pierard, S, Vancraeynest, D, Sinnaeve, F, L Andrade, J, Staszko, K, Dos Santos Monteiro, R, H Miglioranza, M, L Shuha, D, Alcantara, M, Cravo, V, Fazzio, L, Felix, A, Iso, M, Musa, C, P Siciliano, A, Villaca Filho, F, Rodrigues, A, Vilela, F, Braga, J, Silva, R, Rodrigues, D, Silva, L, Morhy, S, Fischer, C, Vieira, M, Afonso, T, Abreu, J, N Falcao, S, A Moises, V, Gouvea, A, J Mancuso, F, C Souza, A, Y Silva, C, João, G, S Abboud, C, Bellio de Mattos Barretto, R, Ramos, A, Arnoni, R, E Assef, J, J Della Togna, D, Le Bihan, D, Miglioli, L, P Romero Oliveira, A, Tadeu Magro Kroll, R, Cortez, D, L Gelape, C, C Peirira Nunes, M D, C De Abreu Ferrari, T, Hay, K, Le, V, Page, M, Poulin, F, Sauve, C, Serri, K, Mercure, C, Beaudoin, J, Pibarot, P, A Sebag, I, G Rudski, L, Ricafort, G, Barsic, B, Krajinovic, V, Vargovic, M, Lovric, D, Reskovic-Luksic, V, Vincelj, J, Jaksic Jurinjak, S, Yiannikourides, V, Ioannides, M, Pofaides, C, Masoura, V, Pudich, J, Linhart, A, Siranec, M, Marek, J, Blechova, K, Kamenik, M, Pelouch, R, Coufal, Z, Mikulica, M, Griva, M, Jancova, E, Mikulcova, M, Taborsky, M, Precek, J, Jecmenova, M, Latal, J, Widimsky, J, Butta, T, Machacek, S, Vancata, R, Spinar, J, Holicka, M, Pow Chon Long, F, Anzules, N, Bajana Carpio, A, Largacha, G, Penaherrera, E, Moreira, D, Mahfouz, E, Elsafty, E, Soliman, A, Zayed, Y, Aboulenein, J, Abdel-Hay, M, Almaghraby, A, Abdelnaby, M, Ahmed, M, Hammad, B, Saleh, Y, Zahran, H, Elgebaly, O, Saad, A, Ali, M, Zeid, A, El Sharkawy, R, Al Kholy, A, Doss, R, Osama, D, Rizk, H, Elmogy, A, Mishriky, M, Assayag, P, El Hatimi, S, Hubert, S, Casalta, J-P, Gouriet, F, Arregle, F, Cammilleri, S, Tessonnier, L, Riberi, A, Botelho-Nevers, E, Gagneux-Brunon, A, Pierrard, R, Tulane, C, Campisi, S, Fuzellier, J-F, Detoc, M, Mehalla, T, Boutoille, D, S Lecompte, A, Lefebvre, M, Pattier, S, Al Habash, O, Asseray-Madani, N, Biron, C, Brochard, J, Caillon, J, Cueff, C, Le Tourneau, T, Lecomte, R, M Magali Michel, M, Orain, J, Delarue, S, Le Bras, M, Faucher, J-F, Aboyans, V, Beeharry, A, Durox, H, Lacoste, M, Magne, J, Mohty, D, David, A, Pradel, V, Sierra, V, Neykova, A, Bettayeb, B, Elkentaoui, S, Tzvetkov, B, Landry, G, Strady, C, Ainine, K, Baumard, S, Brasselet, C, Tassigny, C, Valente-Pires, V, Lefranc, M, Hoen, B, Lefevre, B, Curlier, E, Callier, C, Fourcade, N, Jobic, Y, Ansard, S, Le Berre, R, Le Ven, F, Pouliquen, M-C, Prat, G, Le Roux, P, Bouchart, F, Savoure, A, Alarcon, C, Chapuzet, C, Gueit, I, Tribouilloy, C, Bohbot, Y, Peugnet, F, Gun, M, Duval, X, Lescure, X, Ilic-Habensus, E, Sadoul, N, Selton-Suty, C, Alla, F, Goehringer, F, Huttin, O, Chevalier, E, Garcia, R, Le Marcis, V, Tattevin, P, Flecher, E, Revest, M, Chirouze, C, Bouiller, K, Hustache-Mathieu, L, Klopfenstein, T, Moreau, J, Fournier, D, Brunel, A-S, Lim, P, Oliver, L, Ternacle, J, Moussafeur, A, Chavanet, P, Piroth, L, Salmon-Rousseau, A, Buisson, M, Mahy, S, Martins, C, Gohier, S, Axler, O, Baumann, F, Lebras, S, Piper, C, Guckel, D, Börgermann, J, Horstkotte, D, Winkelmann, E, Brockmeier, B, Grey, D, Nickenig, G, Schueler, R, Öztürk, C, Stöhr, E, Hamm, C, Walther, T, Brandt, R, Frühauf, A-C, T Hartung, C, Hellner, C, Wild, C, Becker, M, Hamada, S, Kaestner, W, Stangl, K, Knebel, F, Baldenhofer, G, Brecht, A, Dreger, H, Isner, C, Pfafflin, F, Stegemann, M, Zahn, R, Fraiture, B, Kilkowski, C, Karcher, A-K, Klinger, S, Tolksdorf, H, Tousoulis, D, Aggeli, C, Sideris, S, Venieri, E, Sarri, G, Tsiapras, D, Armenis, I, Koutsiari, A, Floros, G, Grassos, C, Dragasis, S, Rallidis, L, Varlamos, C, Michalis, L, Naka, K, Bechlioulis, A, Kotsia, A, Lakkas, L, Pappas, K, Papadopoulos, C, Kiokas, S, Lioni, A, Misailidou, S, Barbetseas, J, Bonou, M, Kapelios, C, Tomprou, I, Zerva, K, Manolis, A, Hamodraka, E, Athanasiou, D, Haralambidis, G, Samaras, H, Poulimenos, L, Nagy, A, Bartykowszki, A, Gara, E, Mungulmare, K, Kasliwal, R, Bansal, M, Ranjan, S, Bhan, A, Kyavar, M, Maleki, M, Noohi Bezanjani, F, Alizadehasl, A, Boudagh, S, Ghavidel, A, Moradnejad, P, R Pasha, H, Ghadrdoost, B, Gilon, D, Strahilevitz, J, Wanounou, M, Israel, S, D'Agostino, C, Colonna, P, De Michele, L, Fumarola, F, Stante, M, Marchionni, N, Scheggi, V, Alterini, B, Del Pace, S, Stefano, P, Sparano, C, Ruozi, N, Tenaglia, R, Muraru, D, Limbruno, U, Cresti, A, Baratta, P, Solari, M, Giannattasio, C, Moreo, A, De Chiara, B, Lopez Montero, B, Musca, F, A Orcese, C, Panzeri, F, Spano, F, F Russo, C, Alfieri, O, DE BONIS, Michele, Chiappetta, S, Del Forno, B, Ripa, M, Scarpellini, P, Tassan Din, C, Castiglioni, B, Pasciuta, R, Carletti, S, Ferrara, D, Guffanti, M, Iaci, G, Lapenna, E, Nisi, T, Oltolini, C, Busnardo, E, Pajoro, U, Agricola, E, Meneghin, R, Schiavi, D, Piscione, F, Citro, R, M Benvenga, R, Greco, L, Soriente, L, Radano, I, Prota, C, Bellino, M, Di Vece, D, Santini, F, Salsano, A, M Olivieri, G, Turrini, F, Messora, R, Tondi, S, Olaru, A, Agnoletto, V, Grassi, L, Leonardi, C, Sansoni, S, Del Ponte, S, M Actis Dato, G, De Martino, A, Ohte, N, Kikuchi, S, Wakami, K, Aonuma, K, Seo, Y, Ishizu, T, Machino-Ohtsuka, T, Yamamoto, M, Iida, N, Nakajima, H, Nakagawa, Y, Izumi, C, Amano, M, Miyake, M, Takahashi, K, Shiojima, I, Miyasaka, Y, Maeba, H, Suwa, Y, Taniguchi, N, Tsujimoto, S, Kitai, T, Ota, M, Yuda, S, Sasaki, S, Hagiwara, N, Yamazaki, K, Ashihara, K, Arai, K, Saitou, C, Saitou, S, Suzuki, G, Shibata, Y, Watanabe, N, Nishino, S, Ashikaga, K, Kuriyama, N, Mahara, K, Okubo, T, Fujimaki, H, Shitan, H, Yamamoto, H, Abe, K, Terada, M, Takanashi, S, Sata, M, Yamada, H, Kusunose, K, Saijo, Y, Seno, H, Yuichiro, O, Onishi, T, Sera, F, Nakatani, S, Mizuno, H, Sengoku, K, W Park, S, Eun Kyoung, K, Ga Yeon, L, Hwang, J-W, Jin-Oh, C, Park, S-J, Sang-Chol, L, Sung-A, C, Y Jang, S, Heo, R, Lee, S, Song, J-M, Jung, E, Plisiene, J, Dambrauskaite, A, Gruodyte, G, Jonkaitiene, R, Mizariene, V, Atkocaityte, J, Zvirblyte, R, Sow, R, Codreanu, A, Staub, T, Michaux, C, L De la Vega, E C, Jacobs-Orazi, L, Mallia Azzopardi, C, G Xuereb, R, Piscopo, T, Farrugia, J, Fenech, M, Pllaha, E, Vella, C, Borg, D, Casha, R, Grib, L, Raevschi, E, Grejdieru, A, Kravcenco, D, Prisacari, E, Samohvalov, E, Samohvalov, S, Sceglova, N, Panfile, E, Cardaniuc, L, Corcea, V, Feodorovici, A, Gaina, V, Girbu, L, Jimbei, P, Balan, G, Cardaniuc, I, Benesco, I, Marian, V, Sumarga, N, Bozovic, B, Bulatovic, N, Lakovic, P, Music, L, Budde, R, Wahadat, A, Gamela, T, Meijers, T, P Van Melle, J, M Deursen, V, J Crijns, H, C Bekkers, S, C Cheriex, E, Gilbers, M, L Kietselaer, B, Knackstedt, C, Lorusso, R, Schalla, S, A Streukens, S, Chamuleau, S, Cramer, M-J, Teske, A, Van der Spoel, T, Wind, A, Lokhorst, J, Liesbek, O, Van Heusden, H, Tanis, W, Van der Bilt, I, Vriend, J, De Lange-van Bruggen, H, Karijodikoro, E, Riezebos, R, van Dongen, E, Schoep, J, Stolk, V, T Offstad, J, O Beitnes, J, Helle-Valle, T, Skulstad, H, Skardal, R, Qamar, N, Furnaz, S, Ahmed, B, H Butt, M, F Khanzada, M, Saghir, T, Wahid, A, Hryniewiecki, T, Szymanski, P, Marzec, K, Misztal-Ogonowska, M, Kosmala, W, Przewlocka-Kosmala, M, Rojek, A, Woznicka, K, Zachwyc, J, Lisowska, A, Kaminska, M, D Kasprzak, J, Kowalczyk, E, F Strzecka, D, Wejner-Mik, P, Trabulo, M, Freitas, P, Ranchordas, S, Rodrigues, G, Pinto, P, Queiros, C, Azevedo, J, Marques, L, Seabra, D, Branco, L, Cruz, M, Galrinho, A, Moreira, R, Rio, P, T Timoteo, A, Selas, M, Carmelo, V, Duque Neves, B, Pereira, H, Guerra, A, Marques, A, Pintassilgo, I, C Tomescu, M, Trofenciuc, N-M, Andor, M, Bordejevic, A, S Branea, H, Caruntu, F, A Velcean, L, Mavrea, A, F Onel, M, Parvanescu, T, Pop, D, L Pop-Moldovan, A, I Puticiu, M, Cirin, L, M Citu, I, A Cotoraci, C, Darabantiu, D, Farcas, R, Marincu, I, Ionac, A, Cozma, D, Mornos, C, Goanta, F, Popescu, I, Beyer, R, Mada, R, Rancea, R, Tomoaia, R, Rosianu, H, Stanescu, C, Kobalava, Z, Karaulova, J, Kotova, E, Milto, A, Pisaryuk, A, Povalyaev, N, Sorokina, M, Alrahimi, J, Elshiekh, A, Jamiel, A, Ahmed, A, Attia, N, Putnikovic, B, Dimic, A, Ivanovic, B, Matic, S, Trifunovic, D, Petrovic, J, Kosevic, D, Stojanovic, I, Petrovic, I, Dabic, P, Milojevic, P, Srdanovic, I, Susak, S, Velicki, L, Vulin, A, Kovacevic, M, Redzek, A, Stefanovic, M, C Yeo, T, Kf Kong, W, K Poh, K, Vilacosta, I, Ferrera, C, Olmos, C, Abd El-Nasser, M, Calvo Iglesias, F, Blanco-Gonzalez, E, Bravo Amaro, M, Lopez-Rodriguez, E, Lugo Adan, J, N Germinas, A, Pazos-Lopez, P, Pereira Loureiro, M, T Perez, M, Raposeiras-Roubin, S, Rasheed Yas, S, Suarez-Varela, M-M, Vasallo Vidal, F, Garcia-Dorado, D, Fernandez-Hidalgo, N, Gonzalez-Alujas, T, Lozano, J, Maisterra, O, Pizzi, N, Rios, R, Bayes-Genis, A, Pedro Botet, L, Vallejo, N, Llibre, C, Mateu, L, Nunez, R, Quesada, D, Berastegui, E, Bosch Portell, D, Aboal Vinas, J, Albert Bertran, X, Brugada Tarradellas, R, Loma-Osorio Ricon, P, Tiron de Llano, C, A Arnau, M, Bel, A, Blanes, M, Osa, A, Anguita, M, Carrasco, F, C Castillo, J, L Zamorano, J, L Moya Mur, J, Alvaro, M, Fernandez-Golfin, C, M Monteagudo, J, Navas Elorza, E, C Farinas Alvarez, M, Aguero Balbin, J, Zarauza, J, F Gutierrez-Diez, J, Arminanzas, C, Arnaiz de Las Revillas, F, Arnaiz Garcia, A, Cobo Belaustegui, M, Fernandez Sampedro, M, Gutierrez Cuadra, M, Garcia Cuello, L, Gonzalez Rico, C, Rodriguez-Alvarez, R, Goikoetxea, J, Montejo, M, M Miro, J, Almela, M, Ambrosioni, J, Moreno, A, Quintana, E, Sandoval, E, Tellez, A, M Tolosana, J, Vidal, B, Falces, C, Fuster, D, Garcia-de-la-Maria, C, Hernandez-Meneses, M, Llopis, J, Marco, F, Ruiz-Zamora, I, Bardaji Ruiz, A, Sanz Girgas, E, Garcia-Pardo, G, Guillen Marzo, M, Rodriguez Oviedo, A, Villares Jimenez, A, Abid, L, Hammami, R, Kammoun, S, S Mourali, M, Mghaieth Zghal, F, Ben Hlima, M, Boudiche, S, Ouali, S, Zakhama, L, Antit, S, Slama, I, Gulel, O, Sahin, M, Karacaglar, E, Kucukoglu, S, Cetinarslan, O, Y Sinan, U, Canpolat, U, Mutlu, B, Atas, H, Dervishova, R, Ileri, C, Alhashmi, J, Tahir, J, Zarger, P, Baslib, F, Woldman, S, Menezes, L, Primus, C, Uppal, R, Bvekerwa, I, Chandrasekaran, B, Kopanska, A, Chambers, J, Hancock, J, Klein, J, Rajani, R, P Ursi, M, Cannata, S, Dworakowski, R, Fife, A, Breeze, J, Browne-Morgan, M, Gunning, M, Streather, S, M Asch, F, Zemedkun, M, Alyavi, B, Uzokov, J, Hôpital de la Timone [CHU - APHM] (TIMONE), Microbes évolution phylogénie et infections (MEPHI), Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Centre National de la Recherche Scientifique (CNRS), University Medical Center Groningen [Groningen] (UMCG), Laboratoire Traitement du Signal et de l'Image (LTSI), Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Pontchaillou [Rennes], Université de Médecine Carol Davila, Guy's and St Thomas' Hospital [London], CHU Henri Mondor, Centre Hospitalier Universitaire de Liège (CHU-Liège), AstraZeneca, Bayer, Edwards Lifesciences, Servier, Abbott Vascular Int., Amgen Cardiovascular, Pfizer Alliance, Daiichi Sankyo Europe GmbH, Alliance Daiichi Sankyo Europe GmbH, Gedeon Richter Plc., Menarini Int. Op., Vifor, Boehringer Ingelheim, Boston Scientific Corporation, Bristol-Myers Squibb, Eli Lilly and Company, UCL - SSS/IREC/CARD - Pôle de recherche cardiovasculaire, UCL - (SLuc) Service de pathologie cardiovasculaire, UCL - (SLuc) Service de pathologies cardiovasculaires intensives, UCL - (SLuc) Service de soins intensifs, Service de cardiologie, Université de la Méditerranée - Aix-Marseille 2-Assistance Publique - Hôpitaux de Marseille (APHM)- Hôpital de la Timone [CHU - APHM] (TIMONE), Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU), CIC - CHU Bichat, Institut National de la Santé et de la Recherche Médicale (INSERM), Service de cardiologie et maladies vasculaires, Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Hôpital Pontchaillou-CHU Pontchaillou [Rennes], Oxford University Hospitals NHS Trust, University of Oxford [Oxford], Université Paris-Est Créteil Val-de-Marne - Faculté de médecine (UPEC Médecine), Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Université de Bordeaux (UB), Research Center [Associazione Nazionale Medici Cardiologi Ospedalieri] (ANMCO Research Center), Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO), Service de cardiologie [Liège], CHU de Liège-Domaine Universitaire du Sart Tilman, Paris-Centre de Recherche Cardiovasculaire (PARCC - UMR-S U970), Université Paris Descartes - Paris 5 (UPD5)-Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Institut National de la Santé et de la Recherche Médicale (INSERM), University of Exeter, Instituto Nacional de Tecnología Agropecuaria, Pergamino, Argentina, Laboratory of In Vivo Cellular and Molecular Imaging, Vrije Universiteit Brussel (VUB), Centre National de la Recherche Scientifique (CNRS), Division of Engineering and Applied Science, California Institute of Technology, California Institute of Technology (CALTECH), Departamento de Biologia de la Reproduccion, Universidad Autónoma Metropolitana Iztapalapa (UAMI), Universidade Federal de Itajubá, Departamento de Física [Coimbra] (DFC), Universidade de Coimbra [Coimbra], Section of Internal Medicine and Endocrine and Metabolic Sciences, Università degli Studi di Perugia (UNIPG), LIP-Coimbra & Department of Physics of the University of Coimbra, Service Hospitalier Frédéric Joliot (SHFJ), Direction de Recherche Fondamentale (CEA) (DRF (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Paris-Saclay, Quebec Heart Institute/Laval Hospital, Université Laval [Québec] (ULaval)-Quebec Heart Institute, Institut Lavoisier de Versailles (ILV), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Centre National de la Recherche Scientifique (CNRS), Institut Hospitalier Universitaire Méditerranée Infection (IHU AMU), CHU Saint-Etienne, Centre Hospitalier Universitaire de Saint-Etienne (CHU de Saint-Etienne), Service des maladies infectieuses et tropicales [CHU Nantes], Centre hospitalier universitaire de Nantes (CHU Nantes), Service de bactériologie et hygiène hospitalière [Nantes], Université de Nantes (UN)-Centre hospitalier universitaire de Nantes (CHU Nantes), Institut du thorax, Université de Nantes (UN)-IFR26-Institut National de la Santé et de la Recherche Médicale (INSERM), Service des Maladies infectieuses et tropicales [CHU Limoges], CHU Limoges, Hôpital Sainte-Marguerite [CHU - APHM] (Hôpitaux Sud ), Centre Hospitalier Universitaire de Reims (CHU Reims), Anesthésie et réanimation en chirurgie cardiaque [CHU Rouen], CHU Rouen, Normandie Université (NU)-Normandie Université (NU), Normandie Université (NU), Service des maladies infectieuses et tropicales [Rouen], Normandie Université (NU)-Normandie Université (NU)-Université de Rouen Normandie (UNIROUEN), Mécanismes physiologiques et conséquences des calcifications cardiovasculaires: rôle des remodelages cardiovasculaires et osseux, Université de Picardie Jules Verne (UPJV)-Institut National de la Santé et de la Recherche Médicale (INSERM), Department of Cardiology [Ospedali del Tigullio], Modèles et méthodes de l'évaluation thérapeutique des maladies chroniques (U738 / UMR_S738), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Diderot - Paris 7 (UPD7), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu [Nancy], Maladies chroniques, santé perçue, et processus d'adaptation (APEMAC), Université de Lorraine (UL), Service des Maladies Infectieuses et Tropicales [CHRU Nancy], Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Service de Cardiologie [CHRU Nancy], Service des maladies infectieuses et réanimation médicale, Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Hôpital Pontchaillou, Service de chirurgie thoracique cardiaque et vasculaire [Rennes], Laboratoire Chrono-environnement - CNRS - UFC (UMR 6249) (LCE), Centre National de la Recherche Scientifique (CNRS)-Université de Franche-Comté (UFC), Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC), service de maladies infectieuses CHU J Minjoz Besancon, Hôpital Jean Minjoz, Centre Hospitalier Régional Universitaire [Besançon] (CHRU Besançon), Département d'infectiologie (CHU de Dijon), Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), Virologie et pathogenèse virale (VPV), Centre National de la Recherche Scientifique (CNRS)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon, Institució Catalana de Recerca i Estudis Avançats (ICREA), Institute for Advanced Studies in Basic Sciences, affiliation inconnue, Dipartamento di Fisica 'E.R. Caianiello', Università degli Studi di Salerno (UNISA), The University of Tokyo, Northern Research Station, Forestry Commission, University of North Carolina [Chapel Hill] (UNC), University of North Carolina System (UNC), Instituto de Plasmas e Fusão Nuclear [Lisboa] (IPFN), Instituto Superior Técnico, Universidade Técnica de Lisboa (IST), Instituto de Investigaciones Marinas (CSIC), Faculté des Sciences Pharmaceutiques, EA 4529, Laboratoire de Biochimie, Université Paris-Sud - Paris 11 (UP11), Istituto di Virologia Vegetale, Università degli studi di Torino (UNITO), Universidad Nacional Autónoma de México (UNAM), Service de Chirurgie Cardiovasculaire, University Hospital of Cruces, Geneva University Hospital (HUG), Institut Jean Le Rond d'Alembert (DALEMBERT), Université Pierre et Marie Curie - Paris 6 (UPMC)-Centre National de la Recherche Scientifique (CNRS), Preventive Medicine Unit, University Hospital Joan XXIII, IISPV, Rovira and Virgili University, Popescu, B, Maggioni, A, Gale, C, Nagy, V, Petronio, A, Ali Tatar-Chentir, N, Badano, L, Cardim, N, Chan, K, Kang, D, Neskovic, A, Sade, L, Tude Rodrigues, A, Plastino, M, Casabe, J, Stollberger, C, Ho, C, Winter, M, Emal, C, Vanoverschelde, J, Andrade, J, Miglioranza, M, Shuha, D, Siciliano, A, Falcao, S, Moises, V, Mancuso, F, Souza, A, Silva, C, Joao, G, Abboud, C, Assef, J, Della Togna, D, Romero Oliveira, A, Gelape, C, Peirira Nunes, M, De Abreu Ferrari, T, Sebag, I, Rudski, L, Casalta, J, Fuzellier, J, Lecompte, A, Magali Michel, M, Faucher, J, Pouliquen, M, Brunel, A, Borgermann, J, Ozturk, C, Stohr, E, Fruhauf, A, Hartung, C, Karcher, A, Pasha, H, Orcese, C, Russo, C, De Bonis, M, Benvenga, R, Olivieri, G, Actis Dato, G, Park, S, Hwang, J, Jang, S, Song, J, De la Vega, E, Xuereb, R, Van Melle, J, Deursen, V, Crijns, H, Bekkers, S, Cheriex, E, Kietselaer, B, Streukens, S, Cramer, M, Offstad, J, Beitnes, J, Butt, M, Khanzada, M, Kasprzak, J, Strzecka, D, Timoteo, A, Tomescu, M, Trofenciuc, N, Branea, H, Velcean, L, Onel, M, Pop-Moldovan, A, Puticiu, M, Citu, I, Cotoraci, C, Yeo, T, Poh, K, Germinas, A, Perez, M, Suarez-Varela, M, Arnau, M, Castillo, J, Zamorano, J, Moya Mur, J, Monteagudo, J, Farinas Alvarez, M, Gutierrez-Diez, J, Miro, J, Tolosana, J, Mourali, M, Yasar, U, Ursi, M, Asch, F, Clinical sciences, Cardio-vascular diseases, Cardiology, Medical Imaging, Cardiovascular Centre (CVC), Service de médecine nucléaire [Marseille], Imagerie MOléculaire pour applications THéranostiques personnalisées (IMOTHEP), Institut FRESNEL (FRESNEL), Aix Marseille Université (AMU)-École Centrale de Marseille (ECM)-Centre National de la Recherche Scientifique (CNRS)-Aix Marseille Université (AMU)-École Centrale de Marseille (ECM)-Centre National de la Recherche Scientifique (CNRS)- Hôpital de la Timone [CHU - APHM] (TIMONE), Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université Paris-Saclay-Direction de Recherche Fondamentale (CEA) (DRF (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Centre National de la Recherche Scientifique (CNRS), Centre National de la Recherche Scientifique (CNRS)-Université Pierre et Marie Curie - Paris 6 (UPMC), MGSOG Scientific staff, MUMC+: MA Cardiologie (9), Cardiologie, RS: Carim - H01 Clinical atrial fibrillation, RS: CARIM - R2.01 - Clinical atrial fibrillation, RS: CARIM - R3.11 - Imaging, Promovendi CD, Fysiologie, MUMC+: MA Med Staf Artsass CTC (9), RS: CARIM - R1.06 - Genetic Epidemiology and Genomics of cardiovascular diseases, MUMC+: MA Med Staf Spec Cardiologie (9), RS: Carim - H02 Cardiomyopathy, RS: CARIM - R2.02 - Cardiomyopathy, CTC, MUMC+: MA Med Staf Spec CTC (9), RS: Carim - V04 Surgical intervention, RS: CARIM - R2.12 - Surgical intervention, RS: FdR IC Aansprakelijkheid, Graduate School, ACS - Heart failure & arrhythmias, Radiotherapy, CCA - Imaging and biomarkers, CCA - Cancer Treatment and Quality of Life, and ACS - Atherosclerosis & ischemic syndromes

Subjects
Male, SURGERY, Embolism, Infective endocarditi, Infective endocarditis, Registry, Valve disease, 030204 cardiovascular system & hematology, 0302 clinical medicine, Africa, Northern, Positron Emission Tomography Computed Tomography, 030212 general & internal medicine, Hospital Mortality, Prospective Studies, Registries, Prospective cohort study, Abscess, Aged, 80 and over, medicine.diagnostic_test, Middle Aged, Staphylococcal Infections, 3. Good health, Cardiac surgery, Community-Acquired Infections, Europe, Treatment Outcome, Positron emission tomography, Echocardiography, Heart Valve Prosthesis, [SDV.IB]Life Sciences [q-bio]/Bioengineering, Female, ECHOCARDIOGRAPHY, Cardiology and Cardiovascular Medicine, Adult, medicine.medical_specialty, Asia, Prosthesis-Related Infections, DIAGNOSIS, 03 medical and health sciences, Fluorodeoxyglucose F18, Internal medicine, Streptococcal Infections, medicine, MANAGEMENT, Journal Article, Humans, Aged, business.industry, EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY, Endocarditis, Bacterial, South America, medicine.disease, Heart failure, Etiology, Radiopharmaceuticals, business, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology, Enterococcus
Abstract

Aims The EURO-ENDO registry aimed to study the management and outcomes of patients with infective endocarditis (IE). Methods and results Prospective cohort of 3116 adult patients (2470 from Europe, 646 from non-ESC countries), admitted to 156 hospitals in 40 countries between January 2016 and March 2018 with a diagnosis of IE based on ESC 2015 diagnostic criteria. Clinical, biological, microbiological, and imaging [echocardiography, computed tomography (CT) scan, 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT)] data were collected. Infective endocarditis was native (NVE) in 1764 (56.6%) patients, prosthetic (PVIE) in 939 (30.1%), and device-related (CDRIE) in 308 (9.9%). Infective endocarditis was community-acquired in 2046 (65.66%) patients. Microorganisms involved were staphylococci in 1085 (44.1%) patients, oral streptococci in 304 (12.3%), enterococci in 390 (15.8%), and Streptococcus gallolyticus in 162 (6.6%). 18F-fluorodeoxyglucose positron emission tomography/computed tomography was performed in 518 (16.6%) patients and presented with cardiac uptake (major criterion) in 222 (42.9%) patients, with a better sensitivity in PVIE (66.8%) than in NVE (28.0%) and CDRIE (16.3%). Embolic events occurred in 20.6% of patients, and were significantly associated with tricuspid or pulmonary IE, presence of a vegetation and Staphylococcus aureus IE. According to ESC guidelines, cardiac surgery was indicated in 2160 (69.3%) patients, but finally performed in only 1596 (73.9%) of them. In-hospital death occurred in 532 (17.1%) patients and was more frequent in PVIE. Independent predictors of mortality were Charlson index, creatinine > 2 mg/dL, congestive heart failure, vegetation length > 10 mm, cerebral complications, abscess, and failure to undertake surgery when indicated. Conclusion Infective endocarditis is still a life-threatening disease with frequent lethal outcome despite profound changes in its clinical, microbiological, imaging, and therapeutic profiles.

Published
2019
Full Text
View/download PDF

12. Prognostic significance of serum γ-glutamyltransferase in patients with castration-resistant prostate cancer treated with enzalutamide

Author

Fumitaka Koga, Y. Nakanishi, K. Sakamoto, H. Suzuki, M. Kataoka, Masaaki Ito, K. Tobisu, K. Takemura, and N. Iida

Subjects
Oncology, medicine.medical_specialty, business.industry, Urology, Castration resistant, medicine.disease, Prostate cancer, chemistry.chemical_compound, chemistry, Internal medicine, medicine, Enzalutamide, In patient, business
Published
2019
Full Text
View/download PDF

15. Antislip Readhesion Control Based on Speed-Sensorless Vector Control and Disturbance Observer for Electric Commuter Train—Series 205-5000 of the East Japan Railway Company

Author

M.. Takagi, Tadashi Hata, N.. Iida, Kiyoshi Ohishi, T. Sano, Shinobu Yasukawa, and Satoshi Kadowaki

Subjects
Engineering, Vector control, Computer simulation, business.industry, Bogie, Automotive engineering, Control and Systems Engineering, Control theory, Control system, Torque, Railway engineering, Electrical and Electronic Engineering, business, Induction motor, Slip (vehicle dynamics)
Abstract

The improvement of adhesion characteristics is important in electric commuter train. The electric commuter train has both a slip phenomenon and a slide phenomenon. Slip-and-slide phenomena degrade the comfortable riding performance of electric commuter train. We have already proposed an antislip/ antislide readhesion control system based on disturbance observer and sensorless vector control. The effectiveness of the proposed method has been confirmed by the experiment and the numerical simulation using the tested bogie system of electric commuter train. Then, we apply the proposed method to the actual electric commuter train of series 205-5000 of the East Japan Railway Company. In the experimental results of series 205-5000, this paper demonstrates that the proposed antislip/slide readhesion control system has the desired driving wheel torque response. Moreover, this paper discusses the evaluation method of readhesion control test results.

Published
2007
Full Text
View/download PDF

17. Cyclosporin A therapy for interstitial pneumonitis associated with rheumatic disease

Author

Hiroshi Kaneko, Toru Fukazawa, Souichiro Ando, Taketo Fujii, Hiroshi Hashimoto, Iwao Sekigawa, Naoto Tamura, N Iida, H Ogasawara, Tetsuro Yano, Atsuko Murashima, Shigeto Kobayashi, Yoshinari Takasaki, Kaoru Hirokawa, and Yoshiaki Tokano

Subjects
medicine.medical_specialty, business.industry, Hypoxia (medical), Dermatomyositis, medicine.disease, Polymyositis, Gastroenterology, Rheumatology, Interstitial pneumonitis, Mixed connective tissue disease, Cyclosporin a, Internal medicine, Rheumatoid arthritis, Immunology, medicine, medicine.symptom, business
Abstract

To determine the efficacy of cyclosporin A (CysA) for the treatment of steroid-resistant interstitial pneumonitis (IP), we enrolled 25 patients with various rheumatic diseases and steroid-resistant IP in a pilot study [4 patients with rheumatoid arthritis (RA), 2 with systemic lupus erythematosus (SLE), 11 with polymyositis/dermatomyositis (PM/DM), 4 with systemic sclerosis (SSc), 1 with mixed connective tissue disease (MCTD), 3 with Sjögren syndrome (SS)]. Twelve patients (48%) showed a persistent response to CysA therapy, and 7 of them had PM/DM, including so-called amyopathic DM. Patients with a persistent response had moderately elevated lactate dehydroxygenase (LDH) levels, whereas patients who died had much higher LDH levels and hypoxia. Even patients with low blood levels of CysA achieved a persistent response. In responding patients, the symptoms, chest X-ray findings, arterial oxygen tension, and LDH level all improved after less than 4 weeks. In conclusion, CysA seem to be useful for treating patients with steroid-resistant IP, whose duration is short and severity is mild.

Published
2002
Full Text
View/download PDF

18. Room temperature scanning Hall probe microscopy of localized magnetic field fluctuations on the surfaces of magnetic recording media, permanent magnets and crystalline garnet films in external bias fields

Author

Hiroshi Masuda, Ahmet Oral, Adarsh Sandhu, N Iida, and Simon J. Bending

Subjects
Scanning Hall probe microscope, Hall Effect, Materials science, Microdomains, Magnetic domain, Condensed matter physics, Magnetometer, Garnets, Condensed Matter Physics, Electronic, Optical and Magnetic Materials, law.invention, Magnetic field, Condensed Matter::Materials Science, Magnetization, Domain wall (magnetism), Ferromagnetism, law, Hall effect, Ferromagnets, Magnetic Recording Media
Abstract

A sub-micron room temperature scanning Hall probe microscope (RT-SHPM) was used for real-time imaging of surface magnetic domains of floppy disks, Sr ferrite magnets and Bi-substituted iron garnets placed in large external bias fields. Domain wall nucleation was observed in the garnets where bubble lattices expanded, collapsed and transformed into stripe domains in cyclic bias fields. Evolution of RT-SHPM images was compared with conventional vibrating sample magnetometer measurements.

Published
2002
Full Text
View/download PDF

19. Lessons from Similarities between SLE and HIV Infection

Author

T Hishikawa, Hiroshi Kaneko, Toshio Naito, H Ogasawara, M Okada, Hiroshi Hashimoto, Iwao Sekigawa, and N Iida

Subjects
Microbiology (medical), medicine.medical_specialty, Systemic disease, Lupus erythematosus, business.industry, Incidence, HIV Infections, Disease, medicine.disease, Models, Biological, Connective tissue disease, Retroviridae, Infectious Diseases, Acquired immunodeficiency syndrome (AIDS), immune system diseases, Immunopathology, Immunology, Epidemiology, medicine, Humans, Lupus Erythematosus, Systemic, Viral disease, skin and connective tissue diseases, business
Abstract

Objective : We attempted to obtain deeper understanding of systemic lupus erythematosus (SLE) and human immunodeficiency virus (HIV) infection through comparative studies between both diseases. Method : For this purpose, we reviewed and discussed lessons from similarities in both diseases based on our own and reported findings in literatures. Result : Such comparative studies may contribute to the progress in understanding the clinical or pathogenetic features of these diseases. Conclusion : Further studies into the relationship between SLE and HIV infection may bring to light important clues to assist in the development of better treatments for each disease.

Published
2002
Full Text
View/download PDF

20. Augmentation with hydroxyapatite graft for treating nasal hypoplasia associated with Binderoid complete cleft lip

Author

Y. Ando, A. Watanabe, and N. Iida

Subjects
Male, medicine.medical_specialty, Adolescent, Cephalometry, medicine.medical_treatment, Cleft Lip, Nose, Patient Care Planning, Rhinoplasty, Imaging, Three-Dimensional, Nasal Cartilages, medicine, Humans, Nasal Bone, Nasal cartilages, business.industry, Anterior nasal spine, Craniometry, Nasal bone, medicine.disease, Hypoplasia, Surgery, Skull, medicine.anatomical_structure, Durapatite, Otorhinolaryngology, Bone Substitutes, Oral Surgery, business, Tomography, X-Ray Computed, Follow-Up Studies
Abstract

e report the use of a made-to-order hydroxyapatite Apaceram®, Pentax) onlay graft for the augmentation of asal hypoplasia associated with a binderoid complete cleft ip. The patient was a 16-year-old boy who was born with a omplete cleft lip on the right side. At the age of 4 months e had a rhinocheiloplasty. As he grew the hypoplasia of his idface became more apparent because the nasal bone failed o grow properly, and he was diagnosed with binderoid comlete cleft lip. Lateral cephalometric radiographs were taken eriodically, and growth of the facial bones was judged to ave ceased almost completely by the age of 15 years. Subseuently, at the age of 16, we planned augmentation to treat his asal hypoplasia. Preoperatively his face was characterised y a flat nose and a short columella (Fig. 1). In addition, the asal dorsal cartilage, alar cartilage, and anterior nasal spine ere not palpable. We planned to augment his midface with a made-to-order ydroxyapatite onlay graft to improve his nasal hypoplasia. 3-dimensional model of his skull and facial bones was preared from computed tomographic (CT) data, and clay was ttached to the nasal bone to make his external appearance s normal as possible. On the basis of this model, a hydroxypatite graft with 15% porosity was made to order (Fig. 2). t the same time a hole 2.5 mm in diameter was made in the

Published
2014

21. Two cases of reactive hemophagocytic syndrome: a patient with adult-onset Still's disease and a patient with herpes zoster and autoimmune abnormalities

Author

Iwao Sekigawa, Masuyuki Nawata, Hiroshi Hashimoto, J. Susuki, R. Wada, Michiaki Koike, and N Iida

Subjects
medicine.medical_specialty, Pathology, biology, business.industry, Connective tissue, Disease, Rheumatology, medicine.anatomical_structure, Immune system, Internal medicine, Immunology, medicine, biology.protein, Reactive Hemophagocytic Syndrome, Bone marrow, Hemophagocytosis, Antibody, business
Abstract

We report two cases of bone marrow hemophagocytosis. One patient had adult-onset Still's disease, and the other had herpes zoster associated with potential autoimmune abnormalities. Our findings suggested a pos-sible role of cytokines and/or antibodies in the induction of hemophagocytosis in patients with connective tissue diseases and/or immune abnormalities.

Published
2001
Full Text
View/download PDF

22. A Possible Pathogenic Role of CD8+T Cells and their Derived Cytokine, IL-16, in SLE

Author

Masakazu Matsushita, N Iida, Nobuki Maeda, Iwao Sekigawa, Hiroshi Kaneko, H Ogasawara, Shouseki Lee, and Hiroshi Hashimoto

Subjects
CD4-Positive T-Lymphocytes, Interleukin-16, Lupus erythematosus, medicine.medical_treatment, T cell, Immunology, CD4-CD8 Ratio, Interleukin, CD8-Positive T-Lymphocytes, Biology, Lymphocyte Activation, medicine.disease, Interleukin 21, Cytokine, medicine.anatomical_structure, immune system diseases, medicine, Humans, Lupus Erythematosus, Systemic, Immunology and Allergy, Cytotoxic T cell, Interleukin 16, skin and connective tissue diseases, CD8
Abstract

Current investigations into the role of CD8+ T cells and their derived cytokine, interleukin (IL)-16, in the induction of CD4+ T cell abnormalities in systemic lupus erythematosus (SLE) were reviewed and discussed on the basis of results mainly obtained in our laboratory.

Published
2001
Full Text
View/download PDF

23. Measurement of the cross-section and forward-backward charge asymmetry for the b and c-quark in $e^+e^-$ annihilation with inclusive muons at $\sqrt{s} = 58$ GeV

Author

Y. Inoue, A. Miyamoto, E. Nakano, T. Takahashi, T. Tauchi, Y. Teramoto, K. Abe, T. Abe, I. Adachi, K. Adachi, M. Aoki, R. Enomoto, K. Emi, H. Fujii, K. Fujii, T. Fujii, J. Fujimoto, N. Fujiwara, H. Hirano, B. Howell, H. Hayashii, N. Iida, H. Ikeda, S. Itami, R. Itoh, H. Iwasaki, M. Iwasaki, R. Kajikawa, K. Kaneyuki, S. Kato, S. Kawabata, H. Kichimi, M. Kobayashi, D. Koltick, I. Levine, H. Mamada, K. Miyabayashi, K. Muramatsu, K. Nagai, K. Nakabayashi, M. Nakamura, S. Noguchi, O. Nitoh, A. Ochi, F. Ochiai, N. Ohishi, Y. Ohnishi, Y. Ohshima, H. Okuno, T. Okusawa, E. Shibata, A. Sugiyama, H. Sugiyama, S. Suzuki, K. Takahashi, T. Tanimori, M. Tomoto, T. Tsukamoto, T. Tsumura, S. Uno, Y. Watanabe, A. Yamamoto, and M. Yamauchi

Subjects
Quark, Physics, Particle physics, Annihilation, Muon, Luminosity (scattering theory), Physics and Astronomy (miscellaneous), media_common.quotation_subject, Hadron, FOS: Physical sciences, Astrophysics::Cosmology and Extragalactic Astrophysics, Asymmetry, High Energy Physics - Experiment, Standard Model, Charm quark, High Energy Physics - Experiment (hep-ex), High Energy Physics::Experiment, Astrophysics::Earth and Planetary Astrophysics, Nuclear Experiment, Engineering (miscellaneous), media_common
Abstract

We have studied inclusive muon events using all the data collected by the TOPAZ detector at sqrt(s)=58 GeV with an integrated luminosity of 273pb-1. From 1328 inclusive muon events, we measured the ratio R_qq of the cross section for qq-bar production to the total hadronic cross section and forward-backward asymmetry A^q_FB for b and c quarks. The obtained results are R_bb = 0.13+-0.02(stat)+-0.01(syst), R_cc = 0.36+-0.05(stat)+-0.05(syst), A^b_FB = -0.20+-0.16(stat)+-0.01(syst) and A^c_FB = -0.17+-0.14(stat)+-0.02(syst), in fair agreement with a prediction of the standard model., Comment: To be published in EPJ C. 24 pages, 12 figures

Published
2000
Full Text
View/download PDF

24. A case of hypopituitarism and primary hypothyroidism associated with antiphospholipid syndrome

Author

Keigo Ikeda, N Iida, Iwao Sekigawa, Hiroshi Hashimoto, Soichiro Ando, and Masakazu Matsushita

Subjects
Adult, Pediatrics, medicine.medical_specialty, business.industry, Immunology, Primary hypothyroidism, General Medicine, Hypopituitarism, Antiphospholipid Syndrome, medicine.disease, Hypothyroidism, Antiphospholipid syndrome, medicine, Humans, Immunology and Allergy, Female, Sheehan's syndrome, business
Abstract

Recent reports have indicated that antiphospholipid antibodies (aPL) are related to other clinical manifestations such as cardiac valve lesions and hemolytic anemia besides the major clinical features of antiphospholipid syndrome (APS), including thrombocytopenia, and recurrent fetal demise. We recently encountered a case of multiple hormonal deficiencies in the pituitary gland and hypothyroidism associated with an APS. Hypopituitarism of the patient had occurred after her delivery and a magnetic resonance imaging (MRI) examination disclosed "empty sella" of the hypophysis, so she was thought to have Sheehan's syndrome. There has been a few reports describing the relationship between aPL and endocrine disorders. aPL-related onset of these diseases may be more frequent than is generally appreciated.

Published
2000
Full Text
View/download PDF

25. Low-Dose Cyclosporin for Multiple Colonic Ulcers Associated with Mixed Connective Tissue Disease

Author

T. Yoshizawa, Shunichi Hirose, N Iida, Michio Matsumoto, S. Abe, Iwao Sekigawa, M. Eguchi, Kaoru Ogawa, Nobuki Maeda, and Hiroshi Hashimoto

Subjects
Adult, Vasculitis, medicine.medical_specialty, Pathology, T-Lymphocytes, CD4-CD8 Ratio, Colonic Diseases, Mixed connective tissue disease, Rheumatology, Internal medicine, Humans, Medicine, Multiple colonic ulcers, Ulcer, Mixed Connective Tissue Disease, business.industry, General Medicine, Cell cycle, medicine.disease, Peripheral, Gastrointestinal disorder, Cyclosporine, Female, business, Infiltration (medical), Immunosuppressive Agents
Abstract

This report describes a patient with multiple colonic ulcers and mixed connective tissue disease. The histological findings of the colonic lesions showed vasculitis with T-cell infiltration, and the peripheral T cells were frequently in the activated phase of the cell cycle. In this patient, low-dose cyclosporin treatment (2.5 mg/kg/day) inhibited the T-cell activation in the peripheral lymphocytes and was very effective in the gastrointestinal disorder, which might be related to T-cell activation. This case suggests the possibility that even low-dose cyclosporin can exert a great influence on peripheral T cells and directly inhibit T-cell activation, thereby improving symptoms related to T-cell activation.

Published
1999
Full Text
View/download PDF

26. Measurement of the jet width in γγ collisions and in e+e− annihilation process at TRISTAN

Author

K. Adachi, H. Hayashii, K. Miyabayashi, S. Noguchi, A. Miyamoto, T. Tauchi, K. Abe, T. Abe, I. Adachi, M. Aoki, R. Enomoto, K. Emi, H. Fujii, K. Fujii, T. Fujii, J. Fujimoto, N. Fujiwara, H. Hirano, B. Howell, N. Iida, H. Ikeda, Y. Inoue, S. Itami, R. Itoh, H. Iwasaki, M. Iwasaki, R. Kajikawa, K. Kaneyuki, S. Kato, S. Kawabata, H. Kichimi, M. Kobayashi, D. Koltick, I. Levine, H. Mamada, K. Muramatsu, K. Nagai, K. Nakabayashi, M. Nakamura, E. Nakano, O. Nitoh, A. Ochi, F. Ochiai, N. Ohishi, Y. Ohnishi, Y. Ohshima, H. Okuno, T. Okusawa, E. Shibata, A. Sugiyama, H. Sugiyama, S. Suzuki, K. Takahashi, T. Takahashi, T. Tanimori, Y. Teramoto, M. Tomoto, T. Tsukamoto, T. Tsumura, S. Uno, Y. Watanabe, A. Yamamoto, and M. Yamauchi

Subjects
Physics, Nuclear and High Energy Physics, Jet (fluid), Particle physics, Annihilation, Astrophysics::High Energy Astrophysical Phenomena, HERA, law.invention, Transverse plane, law, High Energy Physics::Experiment, Nuclear Experiment, Collider, Scaling, Energy (signal processing), Bar (unit)
Abstract

The shape of jets produced in (quasi-) real photon-photon collisions as well as in e^+e^- annihilation process has been studied with a cone jet finding algorithm, using the data taken with the TOPAZ detector at the TRISTAN e^+e^- collider at an average center-of-mass energy of 58 GeV. The results are presented in terms of the jet width as a function of the jet transverse energy(E^{jet}_T) as well as a scaled transverse jet energy, x_T(=2E^{jet}_T/root(s)). The jet width narrows as E^{jet}_T increases; however, at the same value of E^{jet}_T the jet width in gamma-gamma collisions at TRISTAN is significantly narrower than that in gamma p collisions at HERA. By comparing our results with the data in other reactions, it has been shown that the jet width in gamma-gamma, gamma p, p\bar{p} collisions as well as the e^+e^- annihilation process has an approximate scaling behavior as a function of x_T.

Published
1999
Full Text
View/download PDF

27. Exacerbation of systemic lupus erythematosus related to cytomegalovirus infection

Author

Iwao Sekigawa, Shouseki Lee, N Iida, T Hayashi, Y Tomino, H Ogasawara, Hiroshi Hashimoto, and Shunichi Hirose

Subjects
Adult, Exacerbation, Prednisolone, Anti-Inflammatory Agents, Congenital cytomegalovirus infection, Cytomegalovirus, Antiviral Agents, Methylprednisolone, 03 medical and health sciences, 0302 clinical medicine, Rheumatology, immune system diseases, medicine, Viral meningitis, Humans, Lupus Erythematosus, Systemic, 030212 general & internal medicine, skin and connective tissue diseases, Ganciclovir, Proteinuria, Lupus erythematosus, biology, business.industry, Immunoglobulins, Intravenous, virus diseases, medicine.disease, Thrombocytopenia, 030227 psychiatry, Cytomegalovirus infection, Cytomegalovirus Infections, DNA, Viral, Immunology, biology.protein, Female, medicine.symptom, Antibody, business, Anti-SSA/Ro autoantibodies
Abstract

We report two patients with systemic lupus erythematosus (SLE) in whom cytomegalovirus (CMV) infection may have played a significant role in the exacerbation or onset of symptoms. The first patient had thrombocytopenia and the second had proteinuria. CMV infection was observed in both patients when their symptoms developed.

Published
1998
Full Text
View/download PDF

28. Effect of extremely low dose cyclosporine treatment on the thrombocytopenia in systemic lupus erythematosus

Author

Hiroshi Kaneko, T Hishikawa, H Ogasawara, Hiroshi Hashimoto, Shunichi Hirose, Iwao Sekigawa, M Sugiyama, and N Iida

Subjects
Adult, 030203 arthritis & rheumatology, medicine.medical_specialty, Lupus erythematosus, business.industry, Low dose, 030204 cardiovascular system & hematology, medicine.disease, Thrombocytopenia, Dermatology, Transplantation, 03 medical and health sciences, 0302 clinical medicine, Rheumatology, Cyclosporine, Humans, Lupus Erythematosus, Systemic, Medicine, Female, business, Adverse effect, Immunosuppressive Agents
Abstract

Cyclosporine is widely known to be effective in cases involving both transplantation as well as a spectrum of immune-mediated diseases, although careful monitoring is required for the preemptive detection of its adverse effects. Here we report the successful treatment by extremely low dose cyclosporine (1 mg/kg per day) of two patients with thrombocytopenia in systemic lupus erythematosus.

Published
1998
Full Text
View/download PDF

29. Design and evaluation of microheater combined QCM array for thermal desorption spectroscopy

Author

Masayuki Sohgawa, N. Iida, Jumpei Sakai, and Takashi Abe

Subjects
Microheater, Crystal, Adsorption, Materials science, Thermal desorption spectroscopy, Desorption, Electrode, Analytical chemistry, Infrared spectroscopy, Quartz crystal microbalance
Abstract

In this paper, we propose a single microheater combined quartz crystal microbalance array for thermal desorption spectroscopy. The each QCM has two electrodes for exciting thickness shear mode (TSM) vibrations on one side of the crystal and a double-spiral-shape heater on the other side. The resonance frequency is stable when a voltage was applied on the microheater. Carbon microparticles for gas adsorption were coated on one of the QCMs and the frequency change during temperature increase was extracted by subtracting the change of the other QCM. The proposed QCM array can monitor small mass changes at sub-ng level as a function of temperature.

Published
2013
Full Text
View/download PDF

30. Development of DONET2 — Off Kii chanel observatory network

Author

E. Araki, Katsuyoshi Kawaguchi, K. Hishiki, N. Fujiwara, Yoshiyuki Kaneda, N. Iida, Y. Kogure, Narumi Takahashi, and T. Katayama

Subjects
Development (topology), Emergency management, business.industry, Software deployment, Observatory, Submarine, Scale (map), business, Network topology, Geology, Seismology, Communication channel
Abstract

DONET is a flexible and expandable submarine cabled seafloor observation infrastructure for mega-thrust earthquake research and disaster prevention. The system which consists of a backbone looped submarine cable system, five science nodes and 20 set of state of art earthquake and tsunami observatories was developed and constructed in the program started from 2006 and fully in operation from 2011 at the hypothesis region of To-Nankai earthquake. Simultaneously with the construction of original DONET, the development and deployment of second DONET system (DONET2) was planned and started in 2010 to subject for the hypothesis region of Nankai earthquake. Since this region spreads out in the wide area about 2 times rather than the region of the To-Nankai earthquake, deployment of a large-scale observation network system is required. Expansion of scale of observatory means the increase of power distribution capacity and the confliction of network topology, it will need to solve the several engineering subject to expand the design of original DONET to large scale system DONET2. This paper describe several indispensable technologies of submarine cabled seafloor observation system DONET (power consumption control, power blanching and time synchronization), then introduce the novel engineering approach for high voltage power distribution control and large scale network topology management for DONET2 off Kii channel observatory network.

Published
2013
Full Text
View/download PDF

31. Leukocyte‐derived growth factor links the PDGF and CXC chemokine families of peptides

Author

M Haisa, D Pencev, Gary R. Grotendorst, A Igarashi, and N Iida

Subjects
Neutrophil-Activating Peptide 2, medicine.medical_treatment, Molecular Sequence Data, Biochemistry, Chemokine receptor, Leukocytes, Genetics, medicine, Humans, Amino Acid Sequence, CXC chemokine receptors, Protein Precursors, Growth Substances, CXCL14, Molecular Biology, Platelet-Derived Growth Factor, biology, Chemistry, Growth factor, Recombinant Proteins, Cell biology, CXCL1, biology.protein, CXCL9, Chemokines, Sequence Alignment, Sequence Analysis, Platelet-derived growth factor receptor, Biotechnology
Abstract

Leukocytes produce many biological mediators that orchestrate the subsequent cellular events during wound healing. We have identified a novel cytokine, leukocyte-derived growth factor (LDGF), which is mitogenic for connective tissue cells. Sequence analysis of the LDGF peptide revealed that it is a precursor of other known peptides including platelet basic protein (PBP), connective tissue activating peptide III (CTAP-III), and neutrophil activating peptide 2 (NAP-2). None of these shorter peptides are active as mitogens for fibroblasts. LDGF appears to stimulate fibroblast growth by stimulation of tyrosine kinase activity of the PDGF receptors. One of the truncated products of LDGF, NAP-2, is a potent neutrophil chemoattractant. Peptides larger than NAP-2, such as PBP and CTAP-III, are not active as neutrophil chemoattractants. Collectively, these findings demonstrate that the LDGF peptide must remain intact in order to retain its fibroblast mitogenic activity. If the LDGF peptide is processed to release the carboxyl terminal half to generate NAP-2, a peptide with proinflammatory activity is generated. These results indicate that the multiple peptides produced from the LDGF-PBP gene posses divergent biological activities that could regulate different phases of the repair process.

Published
1996
Full Text
View/download PDF

33. Possible importance of immunoglobulin E in foetal loss by mothers with anti‐SSA antibody

Author

H Ogawa, N. Seta, N Iida, Iwao Sekigawa, Hiroshi Hashimoto, and M. Yamada

Subjects
Adult, Pregnancy, High-Risk, Pregnancy Complications, Cardiovascular, Immunology, Enzyme-Linked Immunosorbent Assay, Immunoglobulin E, Rheumatology, Pregnancy, Prevalence, Humans, Immunology and Allergy, Medicine, Fetal Death, Maternal-Fetal Exchange, Autoantibodies, Probability, Fetus, biology, business.industry, Incidence (epidemiology), Pregnancy Outcome, Autoantibody, General Medicine, Fetal Blood, medicine.disease, Immunodiffusion, stomatognathic diseases, Heart Block, Antibodies, Antinuclear, biology.protein, Female, Antibody, business, Maternal Age, Anti-SSA/Ro autoantibodies
Abstract

The incidence of foetal loss and/or adverse foetal outcomes, including congenital heart block (CHB), has been investigated in mothers with anti-SSA antibody detected by immunodiffusion or counter-immunoelectrophoresis methods. We investigated the relationship between several serum parameters (such as autoantibodies and immunoglobulins) and foetal loss in patients with anti-SSA antibody, measured by enzyme-linked immunosorbent assay (ELISA).Thirty-seven women who showed positivity for anti-SSA antibody and had a history of pregnancy were included in this study. Immunoglobulins and several autoantibodies were assayed by routine laboratory methods at our hospital.Our data indicated that immunoglobulin E (IgE) levels were significantly higher in the anti-SSA antibody positive women with foetal loss than in those without, and that a strong positive correlation between IgE and anti-SSA antibody levels was observed in the former group, but not in the latter.The serum IgE level seems to be an important factor in the occurrence of foetal loss in mothers with anti-SSA antibody detected by ELISA.

Published
2004
Full Text
View/download PDF

35. Observation of excess Λ() production in two-photon processes at TRISTAN

Author

R. Enomoto, K. Abe, T. Abe, I. Adachi, K. Adachi, M. Aoki, S. Awa, K. Emi, H. Fujii, K. Fujii, T. Fujii, J. Fujimoto, K. Fujita, N. Fujiwara, H. Hayashii, B. Howell, N. Iida, R. Itoh, Y. Inoue, H. Iwasaki, M. Iwasaki, K. Kaneyuki, R. Kajikawa, S. Kato, S. Kawabata, H. Kichimi, M. Kobayashi, D. Koltick, I. Levine, S. Minami, K. Miyabayashi, A. Miyamoto, K. Muramatsu, K. Nagai, K. Nakabayashi, E. Nakano, O. Nitoh, S. Noguchi, A. Ochi, F. Ochiai, N. Ohishi, Y. Ohnishi, Y. Ohshima, H. Okuno, T. Okusawa, T. Shinohara, A. Sugiyama, S. Suzuki, K. Takahashi, T. Takahashi, T. Tanimori, T. Tauchi, Y. Teramoto, N. Toomi, T. Tsukamoto, O. Tsumura, S. Uno, T. Watanabe, Y. Watanabe, A. Yamaguchi, A. Yamamoto, and M. Yamauchi

Subjects
Physics, Nuclear and High Energy Physics, Particle physics, Luminosity (scattering theory), Bar (music), Generator (category theory), Production (computer science), Lambda
Abstract

We have carried out inclusive measurements of $\Lambda(\bar{\Lambda})$ production in two-photon processes at TRISTAN. The mean $\sqrt{s}$ was 58 GeV and the integrated luminosity was 265 pb$^{-1}$. Inclusive $\Lambda (\bar{\Lambda})$ samples were obtained under such conditions as no-electron, anti-electron, and remnant-jet tags. The data were compared with theoretical calculations. The measured cross sections are two-times larger than the leading-order theoretical predictions, suggesting the necessity of next-to-leading-order Monte-Carlo generator.

Published
1995
Full Text
View/download PDF

36. Measurement of the total hadronic cross section and determination of γ-Z interference in e+e− annihilation

Author

K. Miyabayashi, I. Adachi, K. Fujii, J. Fujimoto, A. Miyamoto, A. Sugiyama, S. Suzuki, T. Tauchi, K. Abe, T. Abe, K. Adachi, M. Aoki, S. Awa, K. Emi, R. Enomoto, H. Fujii, T. Fujii, K. Fujita, N. Fujiwara, H. Hayashii, B. Howell, N. Iida, H. Ikeda, R. Itoh, Y. Inoue, H. Iwasaki, M. Iwasaki, K. Kaneyuki, R. Kajikawa, S. Kato, S. Kawabata, H. Kichimi, M. Kobayashi, D. Koltick, I. Levine, S. Minami, K. Muramatsu, K. Nagai, K. Nakabayashi, E. Nakano, O. Nitoh, S. Noguchi, A. Ochi, F. Ochiai, N. Ohishi, Y. Ohnishi, Y. Ohshima, H. Okuno, T. Okusawa, T. Shinohara, K. Takahashi, T. Takahashi, T. Tanimori, Y. Teramoto, N. Toomi, T. Tsukamoto, O. Tsumura, S. Uno, T. Watanabe, Y. Watanabe, A. Yamaguchi, A. Yamamoto, and M. Yamauchi

Subjects
Physics, Topaz, Nuclear physics, Nuclear and High Energy Physics, Cross section (physics), Particle physics, Annihilation, Luminosity (scattering theory), Hadron, engineering, engineering.material, Interference (wave propagation)
Abstract

The total hadronic cross section in e + e − annihilation was measured at s =5.77 GeV to be σ h = 143.6 ± 1.5 (stat) ± 3.5 (sys) pb with only the QED corrections. The measurement was based on data corresponding to an integrated luminosity of 90.8 pb −1 accumulated by the TOPAZ detector at TRISTAN. Our data point put stringent constraints on the size of the γ - Z 0 interference and the Z 0 mass. Combining our data with the OPAL data at LEP, we obtained the coefficient of the interference and the Z 0 mass to be J had = 0.10 ± 0.26 and M z = 91.151 ± 0.008 GeV, respectively, in a model-independent analysis.

Published
1995
Full Text
View/download PDF

37. Measurement of inclusive particle spectra and test of MLLA prediction in e+e− annihilation at

Author

R. Itoh, M. Yamauchi, A. Yamaguchi, K. Abe, T. Abe, I. Adachi, K. Adachi, M. Aoki, S. Awa, K. Emi, R. Enomoto, H. Fujii, K. Fujii, T. Fujii, J. Fujimoto, K. Fujita, N. Fujiwara, H. Hayashii, B. Howell, N. Iida, Y. Inoue, H. Iwasaki, M. Iwasaki, K. Kaneyuki, R. Kajikawa, S. Kato, S. Kawabata, H. Kichimi, M. Kobayashi, D. Koltick, I. Levine, S. Minami, K. Miyabayashi, A. Miyamoto, K. Muramatsu, K. Nagai, K. Nakabayashi, E. Nakano, O. Nitoh, S. Noguchi, A. Ochi, F. Ochiai, N. Ohishi, Y. Ohnishi, Y. Ohshima, H. Okuno, T. Okusawa, T. Shinohara, A. Sugiyama, S. Suzuki, K. Takahashi, T. Takahashi, T. Tanimori, T. Tauchi, Y. Teramoto, N. Toomi, T. Tsukamoto, O. Tsumura, S. Uno, T. Watanabe, Y. Watanabe, and A. Yamamoto

Subjects
Quantum chromodynamics, Physics, Momentum, Nuclear and High Energy Physics, Particle physics, Annihilation, Hadron, High Energy Physics::Experiment, Charged particle, Spectral line, Energy (signal processing), Bar (unit)
Abstract

Inclusive momentum spectra are measured for all charged particles and for each of $\pi^{\pm}$, $K^{\pm}$, $K^0/\bar{K^0}$, and $p/\bar{p}$ in hadronic events produced via $e^+e^-$ annihilation at $\sqrt{s}$=58GeV . The measured spectra are compared with QCD predictions based on the modified leading log approximation(MLLA). The MLLA model reproduces the measured spectra well. The energy dependence of the peak positions of the spectra is studied by comparing the measurements with those at other energies. The energy dependence is also well described by the MLLA model.

Published
1995
Full Text
View/download PDF

38. Detection of type C retroviral particles in the lung cells of a patient with systemic lupus erythematosus

Author

N Iida, Naoki Yamamoto, Iwao Sekigawa, Shunichi Hirose, Naoaki Tamura, T Hishikawa, Hiroshi Hashimoto, Kazuo Shimizu, Naoki Maruyama, and Shiro Kira

Subjects
Lung, biology, medicine.diagnostic_test, biology.organism_classification, medicine.disease, Virology, respiratory tract diseases, Idiopathic pulmonary fibrosis, Syncytial cell, Retrovirus, Bronchoalveolar lavage, medicine.anatomical_structure, immune system diseases, Immunology, medicine, biology.protein, Interstitial pneumonia, Antibody, Reverse transcriptase activity, skin and connective tissue diseases
Abstract

Novel type C retroviral particles were detected in the bronchoalveolar lavage fluid (BALF) of a patient who had systemic lupus erythematosus (SLE) with interstitial pneumonia. Syncytial cell formation in the BALF and positive reverse transcriptase activity in the supernatant of the cultured cells were observed. No antibody to known human retroviruses or proviral sequences was detected.Serum antibody to this putative type C retrovirus was also detected in 23.5 % of SLE patients and 26.9 % of idiopathic pulmonary fibrosis patients. This novel type C retroviral particle could be one of the pathogenic agents for SLE or interstitial pneumonia.

Published
1995
Full Text
View/download PDF

39. The Raliability and Validity of a New Self-Completed Questionnaire(QUIK)

Author

N, Iida, N, Kohashi, and W, Koyama

Subjects
Male, business.industry, media_common.quotation_subject, Reproducibility of Results, Regression analysis, Standard deviation, Correlation, Physical functioning, Feeling, Rating scale, Surveys and Questionnaires, Internal consistency, Quality of Life, Humans, Medicine, Female, Geriatrics and Gerontology, Patient group, business, Aged, Clinical psychology, media_common
Abstract

In order to evaluate the reliability and validity of a self-completed questionnaire (QUIK), devised to measured QOL, we examined the QUIK scores of elderly who visited the Kumamoto Health Administrative Center for a medical check-up in March 1994. The QUIK questionnaire, which is a close-ended and disease non-specific questionnaire, covered four domains such as physical functioning, emotional adjustment, interpersonal relationships, and attitudes toward life, interacting reciprocally. The mean and standard deviation on QUIK were much better in terms of total score (5.1 +/- 5.4), for each domain score in comparison with the patient group, and even in comparison with the non-patient group. The distribution of total scores on QUIK were as follows: excellent 15%, good 35%, fair 36%, poor 11%, very poor 2% and grossly impaired 0% according to a six-tiered rating scale. The internal consistency in terms of total score was alpha = 0.86. Very close correlation were seen among score, each domain score and satisfaction, being healthy and present state of feeling. If the cut-off points of total score were set between 9 and 10, the sensitivity were 0.65, specificity was 0.65 for the age index, sensitivity 1.00, validity 0.29 for the satisfaction index, while, sensitivity was 0.85 and validity 0.48, for the feeling index. There was a very close reciprocal correlation among the four domains, except for the relation between physical functioning and interpersonal relationship using multiple regression analysis. Further, significant correlations were obtained between the score in each domain and the score based on subtracting each domain score from the total score.

Published
1995
Full Text
View/download PDF

40. k0 (K̄0) production in two-photon processes at TRISTAN

Author

R. Enomoto, K. Abe, T. Abe, I. Adachi, K. Adachi, M. Aoki, S. Awa, K. Emi, H. Fujii, K. Fujii, T. Fujii, J. Fujimoto, K. Fujita, N. Fujiwara, H. Hayashii, B. Howell, N. Iida, R. Itoh, Y. Inoue, H. Iwasaki, M. Iwasaki, K. Kaneyuki, R. Kajikawa, S. Kato, S. Kawabata, H. Kichimi, M. Kobayashi, D. Koltick, I. Levine, S. Minami, K. Miyabayashi, A. Miyamoto, K. Muramatsu, K. Nagai, K. Nakabayashi, E. Nakano, O. Nitoh, S. Noguchi, A. Ochi, F. Ochiai, N. Ohishi, Y. Ohnishi, Y. Ohshima, H. Okuno, T. Okusawa, T. Shinohara, A. Sugiyama, S. Suzuki, K. Takahashi, T. Takahashi, T. Tanimori, T. Tauchi, Y. Teramoto, N. Toomi, T. Tsukamoto, O. Tsumura, S. Uno, T. Watanabe, Y. Watanabe, A. Yamaguchi, A. Yamamoto, and M. Yamauchi

Subjects
Physics, Nuclear physics, High Energy Physics - Experiment (hep-ex), Nuclear and High Energy Physics, Luminosity (scattering theory), Astrophysics::High Energy Astrophysical Phenomena, FOS: Physical sciences, High Energy Physics::Experiment, Production (computer science), Measure (mathematics), High Energy Physics - Experiment
Abstract

We have carried out an inclusive measurement of $K^0(\bar{K^0})$ production in two-photon processes at TRISTAN. The mean $\sqrt{s}$ was 58 GeV and the integrated luminosity was 199 pb$^{-1}$. High-statistics $K_s$ samples were obtained under such conditions as no-, anti-electron, and remnant-jet tags. The remnant-jet tag, in particular, allowed us, for the first time, to measure the cross sections separately for the resolved-photon and direct processes., Comment: 20 pages, Latex format, 4 figures and KEK-mark included. Table 1 revised. To be published in Phys. Lett. B

Published
1994
Full Text
View/download PDF

41. Measurement of the forward-backward asymmetries for charm- and bottom-quark pair productions at with electron tagging

Author

E. Nakano, R. Enomoto, M. Iwasaki, K. Abe, T. Abe, I. Adachi, K. Adachi, M. Aoki, S. Awa, R. Belusevic, K. Emi, H. Fujii, K. Fujii, T. Fujii, J. Fujimoto, K. Fujita, N. Fujiwara, H. Hayashii, B. Howell, N. Iida, H. Ikeda, R. Itoh, Y. Inoue, H. Iwasaki, K. Kaneyuki, R. Kajikawa, S. Kato, S. Kawabata, H. Kichimi, M. Kobayashi, D. Koltick, I. Levine, S. Minami, K. Miyabayashi, A. Miyamoto, K. Muramatsu, K. Nagai, K. Nakabayashi, O. Nitoh, S. Noguchi, A. Ochi, F. Ochiai, N. Ohishi, Y. Ohnishi, Y. Ohshima, H. Okuno, T. Okusawa, T. Shinohara, A. Sugiyama, S. Suzuki, K. Takahashi, T. Takahashi, T. Tanimori, T. Tauchi, Y. Teramoto, N. Toomi, T. Tsukamoto, O. Tsumura, S. Uno, T. Watanabe, Y. Watanabe, A. Yamaguchi, A. Yamamoto, and M. Yamauchi

Subjects
Topaz, Physics, Nuclear and High Energy Physics, Particle physics, Detector, Hadron, engineering, Forward backward, Electron, Charm (quantum number), engineering.material, Bottom quark, Standard Model
Abstract

We have measured, with electron tagging, the forward-backward asymmetries of charm- and bottom-quark pair productions at $ $=58.01GeV, based on 23,783 hadronic events selected from a data sample of 197pb$^{-1}$ taken with the TOPAZ detector at TRISTAN. The measured forward-backward asymmetries are $A_{FB}^c = -0.49 \pm 0.20(stat.) \pm 0.08 (sys.)$ and $A_{FB}^b = -0.64 \pm 0.35(stat.) \pm 0.13 (sys.)$, which are consistent with the standard model predictions.

Published
1994
Full Text
View/download PDF

42. Measurement of inclusive electron cross section in γγ collisions at TRISTAN

Author

M. Iwasaki, R. Enomoto, H. Hayashii, E. Nakano, K. Abe, T. Abe, I. Adachi, K. Adachi, M. Aoki, S. Awa, K. Emi, H. Fujii, K. Fujii, T. Fujii, J. Fujimoto, K. Fujita, N. Fujiwara, B. Howell, N. Iida, H. Ikeda, Y. Inoue, R. Itoh, H. Iwasaki, R. Kajikawa, K. Kaneyuki, S. Kato, S. Kawabata, H. Kichimi, M. Kobayashi, D. Koltick, I. Levine, S. Minami, K. Miyabayashi, A. Miyamoto, K. Muramatsu, K. Nagai, K. Nakabayashi, O. Nitoh, S. Noguchi, A. Ochi, F. Ochiai, N. Ohishi, Y. Ohnishi, Y. Ohshima, H. Okuno, T. Okusawa, T. Shinohara, A. Sugiyama, S. Suzuki, K. Takahashi, T. Takahashi, T. Tanimori, T. Tauchi, Y. Teramoto, N. Toomi, T. Tsukamoto, T. Tsumura, S. Uno, T. Watanabe, Y. Watanabe, A. Yamaguchi, A. Yamamoto, and M. Yamauchi

Subjects
Physics, Nuclear and High Energy Physics, Particle physics, Luminosity (scattering theory), Astrophysics::High Energy Astrophysical Phenomena, High Energy Physics::Phenomenology, Hadron, Order (ring theory), Electron, law.invention, Gluon, Charm quark, Positron, law, High Energy Physics::Experiment, Nuclear Experiment, Collider
Abstract

We have studied open charm production in $\gamma \gamma$ collisions with the TOPAZ detector at the TRISTAN $e^{+}e^{-}$ collider. In this study, charm quarks were identified by electrons (and positrons) from semi-leptonic decays of charmed hadrons. The data corresponded to an integrated luminosity of 95.3 pb$^{-1}$ at a center-of-mass energy of 58 GeV. The results are presented as the cross sections of inclusive electron production in $\gamma \gamma$ collisions with an anti-tag condition, as well as the subprocess cross sections, which correspond to resolved-photon processes. The latter were measured by using a sub-sample with remnant jets. A comparison with various theoretical predictions based on direct and resolved-photon processes showed that our data prefer that with relatively large gluon contents in a photon at small $x (x \le 0.1)$, with the next-to-leading order correction, and with a charm-quark mass of 1.3 GeV.

Published
1994
Full Text
View/download PDF

43. Measurement of the photon structure function F2γ and jet production at TRISTAN

Author

K. Muramatsu, H. Hayashii, S. Noguchi, N. Fujiwara, K. Abe, T. Abe, I. Adachi, M. Aoki, S. Awa, R. Belusevic, K. Emi, R. Enomoto, H. Fujii, K. Fujii, T. Fujii, J. Fujimoto, K. Fujita, B. Howell, N. Iida, H. Ikeda, R. Itoh, H. Iwasaki, M. Iwasaki, R. Kajikawa, K. Kaneyuki, S. Kato, S. Kawabata, H. Kichimi, M. Kobayashi, D. Koltick, I. Levine, S. Minami, K. Miyabayashi, A. Miyamoto, K. Nagai, T. Nagira, E. Nakano, K. Nakabayashi, O. Nitoh, F. Ochiai, Y. Ohnishi, H. Okuno, T. Okusawa, K. Shimozawa, T. Shinohara, A. Sugiyama, N. Sugiyama, S. Suzuki, K. Takahashi, T. Takahashi, M. Takemoto, T. Tanimori, T. Tauchi, F. Teramae, Y. Teramoto, N. Toomi, T. Toyama, T. Tsukamoto, S. Uno, T. Watanabe, Y. Watanabe, A. Yamaguchi, A. Yamamoto, and M. Yamauchi

Subjects
Physics, Quantum chromodynamics, Nuclear and High Energy Physics, Particle physics, Photon, Hadron, Detector, Jet (particle physics), engineering.material, Deep inelastic scattering, Photon structure function, Nuclear physics, Topaz, engineering, High Energy Physics::Experiment
Abstract

We have measured the photon structure function F2γ in the reaction e+e− → e+e− hadrons for average Q2 values from 5.1 to 338 GeV2 by using data collected by the TOPAZ detector at TRISTAN. The data have been corrected for detector effects and are compared with theoretical expectations based on QCD. The structure function F2γ increases as ln Q2, as expected. A sample of events with one or two distinct jets has been identified in the final state. Although two-jet events can be explained solely by the point-like perturbative part, one-jet events require a significant hadron-like part in addition.

Published
1994
Full Text
View/download PDF

44. Measurement of the forward-backward asymmetry of

Author

K. Miyabayashi, K. Emi, S. Kawabata, Osamu Nitoh, T. Takahashi, K. Takahashi, K. Abe, I. Adachi, Hirokazu Ikeda, F. Teramae, H. Hayashii, T. Toyama, Koichi Nagai, N. Sugiyama, H. Kichimi, I. Levine, Y. Ohnishi, E. Nakano, R. Itoh, A. Yamaguchi, T. Shinohara, J. Fujimoto, T. Fujii, B. Howell, A. Miyamoto, D.S. Koltick, M. Iwasaki, Tomohiro Abe, Toru Tanimori, N. Toomi, Hiroyuki Iwasaki, Shota Suzuki, F. Ochiai, T. Okusawa, Hideki Okuno, R. Kajikawa, S. Noguchi, K. Muramatsu, T. Tauchi, Masakazu Kobayashi, T. Tsukamoto, K. Shimozawa, S. Uno, R. Belusevic, M. Takemoto, Keisuke Fujii, Y. Teramoto, M. Yamauchi, N. Fujiwara, A. Sugiyama, Ryoji Enomoto, Y. Watanabe, H. Fujii, K. Fujita, N. Iida, T. Nagira, Akira Yamamoto, Masato Aoki, N. Nakabayashi, S. Awa, and S. Kato

Subjects
Physics, Nuclear physics, Nuclear and High Energy Physics, Particle physics, Meson, media_common.quotation_subject, Electron–positron annihilation, Forward backward, Elementary particle, Asymmetry, media_common, Standard Model
Abstract

Measurements of the forward-backward asymmetry of e + e − → cc events were carried out at a mean √s energy of 57.95 GeV at TRISTAN, KEK. The cc events were tagged either by the full-reconstruction of D ∗± or the inclusive P T spectrum of π s ± from D ∗± → D 0 ( D 0 )π s ± . The forward-backward asymmetry was measured to be A FB c = −0.49 −0.13 +0.14 (stat.) ± 0.06 (syst.), consistent with the standard model.

Published
1993
Full Text
View/download PDF

45. Measurement of the inclusive cross section of jets in γγ interactions at TRISTAN

Author

T. Nagira, K. Miyabayashi, K. Emi, A. Yamaguchi, T. Takahashi, M. Aoki, Shiro Suzuki, K. Abe, F. Teramae, H. Hayashii, A. Yamamoto, T. Toyama, F. Ochiai, N. Toomi, M. Iwasaki, E. Nakano, T. Abe, I. Levine, Toru Tanimori, T. Shinohara, Y. Ohnishi, N. Fujiwara, T. Tsukamoto, K. Takahashi, R. Itoh, T. Tauchi, Masakazu Kobayashi, S. Awa, H. Kichimi, R. Kajikawa, K. Muramatsu, Hideki Okuno, K. Shimozawa, A. Sugiyama, K. Nakabayashi, Koichi Nagai, B. Howell, A. Miyamoto, Ryoji Enomoto, S. Uno, H. Fujii, S. Kato, Hiroyuki Iwasaki, K. Fujita, Y. Watanabe, J. Fujimoto, S. Noguchi, Hirokazu Ikeda, R. Belusevic, N. Sugiyama, T. Fujii, S. Kawabata, Osamu Nitoh, T. Okusawa, D.S. Koltick, N. Iida, I. Adachi, M. Takemoto, Keisuke Fujii, M. Yamauchi, and Y. Teramoto

Subjects
Cone algorithm, Physics, Nuclear and High Energy Physics, Particle physics, Jet (fluid), Photon, Astrophysics::High Energy Astrophysical Phenomena, Hadron, Photon structure function, law.invention, Nuclear physics, Cross section (physics), law, Energy flow, High Energy Physics::Experiment, Collider
Abstract

We have investigated the properties of jet production in almost real γγ collisions at √s=58 GeV with the TOPAZ detector at the TRISTAN e+e− collider. The data were analyzed with a jet-clustering method based on a cone algorithm. The jet rate shows evidence for a hard scattering effect of the hadronic constituents of a photon (resolved photon processes). We have also observed a substantial energy flow in the small-angle region, which is additional evidence for resolved photon processes. We present the transverse momentum dependence of the inclusive jet and two-jet cross sections and compare them with different model predictions.

Published
1993
Full Text
View/download PDF

46. Search for a narrow resonance in e+e− collisions between ECM = 58 and 60 GeV

Author

K. Shimozawa, A. Yamaguchi, Makoto Kobayashi, M. Iwasaki, O. Nitoh, S. Kawabata, Toru Tanimori, Iki Adachi, T. Tsukamoto, T. Kishida, N. Fujiwara, Hirokazu Ikeda, T. Nagira, J. Fujimoto, E. Nakano, K. Nakabayashi, R. Belusevic, T. Takahashi, F. Ochiai, B. Howell, T. Okusawa, Y. Watanabe, H. Kichimi, M. Takemoto, Keisuke Fujii, K. Abe, K. Miyabayashi, S. Yamamoto, I. Levine, Y. Ohnishi, Shiro Suzuki, D.S. Koltick, Koichi Nagai, N. Iida, S. Awa, R. Kajikawa, N. Sugiyama, Masato Aoki, A. Sugiyama, Toshiaki Tauchi, S. Noguchi, R. Itoh, N. Toomi, Hiroshi G. Okuno, Y. Teramoto, A. Miyamoto, Ryoji Enomoto, S. Uno, Hiroyuki Iwasaki, T. Shinohara, S. Kato, K. Muramutsu, K. Emi, F. Teramae, K. Takahashi, T. Toyama, H. Fujii, K. Fujita, Toshitsugu Fujii, M. Yamauchi, Akira Yamamoto, and H. Hayashii

Subjects
Physics, Nuclear and High Energy Physics, Range (particle radiation), Particle physics, Scalar (mathematics), Resonance, law.invention, Standard Model, Nuclear physics, law, High Energy Physics::Experiment, Tensor, Collider, Energy (signal processing)
Abstract

We carried out the energy scan between ECM = 58 and 60 GeV at the TRISTAN e+e− collider to search for the possible narrow resonance suggested by the L3 experiment at LEP. The total cross sections are measured for γγ, multihadron, e+e− and μ + μ− production at ten energy points covering this energy range almost uniformly. The results are in good agreement with the Standard Model predictions, and 95% confidence level upper limits are set to Γee × BR of the hypothetical scalar and tensor resonances.

Published
1993
Full Text
View/download PDF

47. Possible triggering effect of cytomegalovirus infection on systemic lupus erythematosus

Author

Masuyuki Nawata, M. Yamada, Iwao Sekigawa, N. Seta, Hiroshi Hashimoto, and N Iida

Subjects
Systemic disease, Adolescent, Prednisolone, Immunology, Congenital cytomegalovirus infection, Cytomegalovirus, Antibodies, Viral, medicine.disease_cause, Polymerase Chain Reaction, Risk Assessment, Herpesviridae, Rheumatology, immune system diseases, Betaherpesvirinae, medicine, Humans, Lupus Erythematosus, Systemic, Immunology and Allergy, skin and connective tissue diseases, Autoimmune disease, Lupus erythematosus, biology, business.industry, virus diseases, General Medicine, medicine.disease, biology.organism_classification, Virology, Connective tissue disease, Cytomegalovirus Infections, DNA, Viral, Female, business, Blood Chemical Analysis, Follow-Up Studies, medicine.drug
Abstract

We report on a patient with systemic lupus erythematosus (SLE) who showed elevated titers of IgM antibodies to cytomegalovirus (CMV), suggesting CMV infection at the onset of SLE. Serum CMV antigens were also detected in the patient. These findings raise the possibility that CMV infection may be related to the onset of SLE in certain patients.

Published
2001
Full Text
View/download PDF

48. Pseudolymphoma of the liver associated with Sjögren's syndrome

Author

Nobuhiro Sato, N Iida, Iwao Sekigawa, Takeo Maekawa, Hiroshi Maekawa, Kaoru Ogawa, Hiroshi Hashimoto, Hironao Okubo, and R. Wada

Subjects
Systemic disease, Pathology, medicine.medical_specialty, Immunology, Pseudolymphoma, Rheumatology, Immunopathology, medicine, Humans, Immunology and Allergy, Autoimmune disease, business.industry, Liver Diseases, General Medicine, Middle Aged, medicine.disease, Magnetic Resonance Imaging, Sjogren's Syndrome, Liver, Female, Histopathology, Sjogren s, Differential diagnosis, business, Liver pathology
Abstract

Sjögren's syndrome (SS) is known to be associated with pseudolymphoma in several organs. We describe a patient with SS complicated by a hepatic pseudolymphoma. Although the development of a hepatic pseudolymphoma is extremely rare, this disorder should be taken into consideration in the differential diagnosis of space occupying lesions related to autoimmune diseases such as SS.

Published
2001
Full Text
View/download PDF

49. Studies of e+e−→γγ and γγγ reactions

Author

K. Harigae, H. Iwasaki, J. Fujimoto, R. Kajikawa, Shiro Suzuki, K. Muramatsu, N. Iida, R. Itoh, T. Tsukamoto, K. Shimozawa, Toru Tanimori, N. Fujiwara, Koichi Nagai, A. Miyamoto, M. Ohkura, T. Takahashi, T. Nagira, Shimpei Yamamoto, S. Noguchi, S. Uno, N. Tachibana, K. Takahashi, T. Tauchi, A. Shimonaka, H. Takamure, A. Shirahashi, A. Sugiyama, Masakazu Kobayashi, Hideki Okuno, Keisuke Fujii, I. Adachi, K. Miyabayashi, H. Nishioka, T. Abe, E. Sakai, Akira Yamamoto, Y. Watanabe, B. Howell, S. Kawabata, E. Nakano, Shigeaki Kato, Y. Kato, I. Levine, Y. Ohnishi, M. Doser, Osamu Nitoh, T. Kamae, F. Ochiai, H. Fujii, Ryoji Enomoto, H. Kichimi, Y. Teramoto, D.S. Koltick, N. Fujio, T. Okusawa, T. Kishida, Hirokazu Ikeda, N. Nakagawa, M. Nakajima, M. Yamauchi, Minoru Nakayama, T. Fujii, S. Hori, and H. Hayashii

Subjects
Massless particle, Nuclear physics, Physics, Nuclear and High Energy Physics, Particle physics, Effective mass (solid-state physics), Annihilation, Electron–positron annihilation, Mass spectrum, Elementary particle, Spectral line, Boson
Abstract

We have measured the cross section for γγ production with the TOPAZ detector in the energy region √ s =50.0–61.4 GeV. The observed cross section for γγ production integrated over |cos θ | ⩽ 0.77 is 50.2±0.8±2.2 pb at 〈√ s 〉=57.6 GeV and the ratio of this value to the QED prediction is 1.01±0.02±0.04. The angular distribution is in good agreement with the QED predictions, thereby setting limits on the compositeness scales, Λ L+R + =168 GeV, Λ L+R − =97 GeV, Λ L,R =141 GeV, Λ L,R − =81 GeV, and Λ L−R ± =68 GeV, at the 95% confidence level. The reaction e + e − → γγγ was also studied and was found consistent with the QED prediction.

Published
1992
Full Text
View/download PDF

50. An experimental study of muon pair production in tagged two-photon interactions

Author

Ryoji Enomoto, Minoru Nakayama, Y. Teramoto, A. Miyamoto, T. Kishida, S. Kawabata, Hirokazu Ikeda, Makoto Kobayashi, H. Takamure, K. Harigae, T. Nagira, S. Noguchi, T. Abe, N. Fujio, S. Kato, N. Fujiwara, Keisuke Fujii, I. Adachi, B. Howell, Toru Tanimori, M. Nakajima, K. Miyabayashi, K. Shimozawa, T. Okusawa, Koichi Nagai, H. Fujii, H. Hayashii, A. Shimonaka, E. Sakai, S. Hori, T. Takahashi, Y. Watanabe, H. Kichimi, K. Takahashi, J. Fujimoto, N. Tachibana, N. Nakagawa, D.S. Koltick, H. Nishioka, Shiro Suzuki, A. Sugiyama, Toshiaki Tauchi, M. Doser, Y. Kato, Toshitsugu Fujii, Hiroshi G. Okuno, I. Levine, M. Yamauchi, Akira Yamamoto, Y. Ohnishi, R. Kajikawa, K. Muramatsu, M. Ohkura, T. Tsukamoto, E. Nakano, A. Shirahashi, S. Uno, T. Kamae, Hiroyuki Iwasaki, S. Yamamoto, N. Iida, R. Itoh, F. Ochiai, and O. Nitoh

Subjects
Physics, Nuclear reaction, Nuclear physics, Nuclear and High Energy Physics, Antiparticle, Pair production, Muon, Luminosity (scattering theory), Antimatter, Mass spectrum, High Energy Physics::Experiment, Lepton
Abstract

The process e + e − →e + e − μ + μ − has been studied in single-tag and double-tag configurations using the TOPAZ detector at TRISTAN. The data correspond to the integrated luminosity of 45.3pb − at center-of-mass energies ranging from 52 to 61.4 GeV. The observed events in both configurations have shown a good agreement with QED predictions in order α 4 . Although the AMY group reported an excess of e + e − →e + e − μ + μ − events in double-tag mode at low muon invariant mass region less than 1.0 GeV/c 2 , we did not observed such excess in our data.

Published
1992
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results